Original Article
A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction
N Engl J Med 2003; 349:733-742August 21, 2003
- Abstract
Background
For the treatment of myocardial infarction with ST-segment elevation, primary angioplasty is considered superior to fibrinolysis for patients who are admitted to hospitals with angioplasty facilities. Whether this benefit is maintained for patients who require transportation from a community hospital to a center where invasive treatment is available is uncertain.
Methods
We randomly assigned 1572 patients with acute myocardial infarction to treatment with angioplasty or accelerated treatment with intravenous alteplase; 1129 patients were enrolled at 24 referral hospitals and 443 patients at 5 invasive-treatment centers. The primary study end point was a composite of death, clinical evidence of reinfarction, or disabling stroke at 30 days.
Results
Among patients who underwent randomization at referral hospitals, the primary end point was reached in 8.5 percent of the patients in the angioplasty group, as compared with 14.2 percent of those in the fibrinolysis group (P=0.002). The results were similar among patients who were enrolled at invasive-treatment centers: 6.7 percent of the patients in the angioplasty group reached the primary end point, as compared with 12.3 percent in the fibrinolysis group (P=0.05). Among all patients, the better outcome after angioplasty was driven primarily by a reduction in the rate of reinfarction (1.6 percent in the angioplasty group vs. 6.3 percent in the fibrinolysis group, P<0.001); no significant differences were observed in the rate of death (6.6 percent vs. 7.8 percent, P=0.35) or the rate of stroke (1.1 percent vs. 2.0 percent, P=0.15). Ninety-six percent of patients were transferred from referral hospitals to an invasive-treatment center within two hours.
Conclusions
A strategy for reperfusion involving the transfer of patients to an invasive-treatment center for primary angioplasty is superior to on-site fibrinolysis, provided that the transfer takes two hours or less.
Media in This Article
Figure 1
Kaplan–Meier Curves Showing Cumulative Event Rates for the Primary Composite End Point of Death, Clinical Reinfarction, or Disabling Stroke during 30 Days of Follow-up.Figure 2
Odds Ratios for the Primary Composite End Point of Death, Reinfarction, or Disabling Stroke at 30 Days of Follow-up among All 790 Patients Randomly Assigned to Primary Angioplasty as Compared with All 782 Patients Randomly Assigned to Fibrinolysis, According to Base-Line Characteristics.Article Activity
- Article
Percutaneous coronary intervention has been shown to be superior to fibrinolysis in the treatment of acute myocardial infarction with ST-segment elevation in patients admitted to highly experienced angioplasty centers.1-4 In Western countries, primary angioplasty is offered only to the limited number of patients admitted directly to hospitals with interventional services. Transportation from the local hospital to an angioplasty center has been considered to represent a major limitation on the widespread use of primary angioplasty. We conducted a community-wide trial to compare the transfer of patients for primary angioplasty with the use of on-site fibrinolysis.
Methods
Study Design
We randomly assigned patients who had myocardial infarction with ST-segment elevation to fibrinolysis or primary angioplasty. From December 1997 to October 2001, we enrolled patients from 24 referral hospitals without angioplasty facilities and 5 invasive-treatment hospitals with such facilities and on-site surgical backup. The participating hospitals served 62 percent of the Danish population. Patients admitted to a referral hospital underwent randomization while they lay on the ambulance stretcher with the crew waiting. Transfer to the nearest angioplasty center had to be completed within three hours. A physician accompanied the patient. All ambulances had resuscitation equipment. The patients were transported directly to the catheterization laboratory.
Treatment
Patients randomly assigned to fibrinolysis received 300 mg of aspirin orally, a beta-blocker intravenously (up to the equivalent of 20 mg of metoprolol), accelerated treatment with tissue plasminogen activator (alteplase, given as a 15-mg bolus and an infusion of 0.75 mg per kilogram of body weight administered over a period of 30 minutes, followed by an infusion of 0.5 mg per kilogram for a period of 60 minutes), and an intravenous bolus of unfractionated heparin (5000 U), followed by a 48-hour infusion of unfractionated heparin. The starting dose of unfractionated heparin was 1000 U per hour; the dose was adjusted to maintain an activated partial-thromboplastin time of 70 to 90 seconds.
Patients randomly assigned to angioplasty received 300 mg of aspirin intravenously, the same dose of a beta-blocker as patients in the fibrinolysis group, and 10,000 U of unfractionated heparin. Additional heparin was given to achieve an activated clotting time of 350 to 450 seconds during the invasive procedure. Platelet glycoprotein IIb/IIIa–receptor blockers were administered at the discretion of the physician. The infarct-related artery was treated if it was totally occluded, if there was a culprit lesion with stenosis of more than 30 percent of the luminal diameter, or if it had a flow grade of less than 3 according to the Thrombolysis in Myocardial Infarction (TIMI) classification.5 Stenting of the culprit lesion was attempted in all patients, unless the vessel had a diameter of less than 2.0 mm. Angioplasty of non–infarct-related arteries was not performed. Patients were not considered for immediate coronary-artery bypass grafting unless they had severe hemodynamic instability. Ticlopidine (500 mg) or clopidogrel (75 mg) was given daily for one month after stenting. The angiograms obtained before and after angioplasty were evaluated by an independent core laboratory (Cardialysis, Rotterdam, the Netherlands).
When failed reperfusion was suspected (i.e., when there was no resolution of ST-segment elevation) or when there was reinfarction or recurrent ischemia with ST-segment elevation after fibrinolysis, the protocol recommended repeated fibrinolysis before consideration of rescue angioplasty. An early or late reinfarction or recurrent ischemia in patients with an index infarction that had been treated by angioplasty was treated by repeated angioplasty.
The primary end point was a composite of death from any cause, clinical reinfarction, or disabling stroke at 30 days of follow-up. Procedure-related reinfarction was not included in the primary end point. A reinfarction was diagnosed if there was an increase in the total creatine kinase and MB isoenzyme activity and either a history of ischemic chest discomfort or electrocardiographic changes. Clinical reinfarction was diagnosed if the creatine kinase MB level increased to above a reference limit in a patient in whom the level had normalized after the index infarction or if there was an increase of at least 50 percent from the last non-normalized measurement. A procedure-related reinfarction was diagnosed after coronary-artery bypass surgery if the creatine kinase MB level increased to five times the upper limit of normal or five times the preceding level; a procedure-related reinfarction was diagnosed after angioplasty if the level increased to twice the upper limit of normal or twice the last non-normalized measurement.
Disabling stroke was defined as a fatal stroke or a stroke causing a clinically significant mental or physical handicap at 30 days of follow-up. Clinically significant handicaps were defined as ranging from slight disability (i.e., the inability to engage in all previous activities in a patient who was still able to take care of himself or herself without assistance) to very severe disability (i.e., a bedridden state involving a requirement for constant nursing care and attention). Detailed definitions of these end points are available elsewhere.6 End-point events were reviewed by an end-points committee that was unaware of the treatment-group assignments.
Criteria for Eligibility
The criteria for inclusion were an age of 18 years or more, the presence of symptoms for at least 30 minutes but less than 12 hours, and cumulative ST-segment elevation of at least 4 mm in at least two contiguous leads. The criteria for exclusion were a contraindication to fibrinolysis, left bundle-branch block, acute myocardial infarction and fibrinolytic treatment within the previous 30 days, pulseless femoral arteries, previous coronary-bypass surgery, renal failure (indicated by a serum creatinine concentration above 2.83 mg per deciliter [250 μmol per liter]), diabetes treated with metformin, nonischemic heart disease, and noncardiac disease associated with a life expectancy of less than 12 months. Patients who were judged to be at high risk during transportation because of cardiogenic shock or severe heart failure (a sustained systolic blood pressure ≤65 mm Hg), persistent life-threatening arrhythmias, or a need for mechanical ventilation were excluded. The study was approved by the National Ethics Committee of Denmark. All eligible patients provided written informed consent. The study was supervised and monitored by an international safety and ethics committee.
At the start of the study, only two centers offered primary angioplasty as routine treatment. Each of the five invasive-treatment centers had to establish a 24-hour service for angioplasty before it was allowed to join the study.
Statistical Analysis
The trial consisted of two simultaneously conducted substudies, one involving patients who underwent randomization at referral hospitals and the other involving patients who underwent randomization at invasive-treatment centers. The results were analyzed both separately for each substudy and for the two substudies combined. Each substudy was designed with two groups, interim analyses, and stopping rules, with an overall two-sided alpha of 5 percent and a power (1 – beta) of 80 percent.
The calculation of the sample size was based on the assumption that the combined primary end point would be reached by 30 days in 16 percent of the patients randomly assigned to fibrinolysis, in 10 percent of the patients randomly assigned to angioplasty at referral hospitals, and in 9 percent of the patients randomly assigned to angioplasty in invasive-treatment centers. Under these assumptions, enrollment of 1100 patients was needed at the referral hospitals, and enrollment of 800 patients was needed at the invasive-treatment centers. Three interim analyses were to be performed in the referral-hospital substudy (after the enrollment of 25 percent, 50 percent, and 75 percent of the patients), and two interim analyses were to be performed in the invasive-treatment–center substudy (after the enrollment of 33 percent and 66 percent of the patients). Thus, each interim analysis was performed after the enrollment of approximately the same number of patients in both substudies.
In case of a treatment difference in favor of fibrinolysis, an alpha level of 0.05 was to be used in all interim analyses. In case of a treatment difference in favor of angioplasty, the significance level at the first interim analysis in each substudy was conservatively set to an alpha level of 0.001, which, together with an overall alpha level of 0.05, led to significance levels at subsequent interim analyses of 0.009 and 0.022 in the referral-hospital substudy and 0.016 in the invasive-treatment–center substudy. The design was a hybrid of a Pocock design and an O'Brien–Fleming design, and analyses were performed with the use of the EaSt software package, version 2.0 (Cytel Software).
If, in any interim analysis in the referral-hospital substudy, angioplasty was shown to be superior to fibrinolysis, both substudies were to be stopped, since the superiority of angioplasty in the referral-hospital substudy would imply its superiority at the invasive-treatment centers as well. If, in any interim analysis in the referral-hospital substudy, angioplasty was shown to be inferior to fibrinolysis, only the referral-hospital substudy was to be stopped. If, in any interim analysis in the invasive-treatment–center substudy, angioplasty was shown to be superior to fibrinolysis, only the invasive-treatment–center substudy was to be stopped. If, in any interim analysis in the invasive-treatment–center substudy, angioplasty was shown to be inferior to fibrinolysis, both substudies were to be stopped, since this would imply the superiority of fibrinolysis at referral hospitals as well.
Results were analyzed according to the intention-to-treat principle. For the comparison of categorical variables, Pearson's chi-square test was used. Values for continuous variables are reported as medians and interquartile ranges. Groups were compared with the use of the Mann–Whitney rank-sum test.
Results
Patient Population and Base-Line Characteristics
A total of 4278 patients who had myocardial infarction with ST-segment elevation were screened for inclusion. Enrollment was stopped on October 1, 2001, after the third interim analysis had demonstrated that angioplasty was superior to fibrinolysis in the referral-hospital substudy. At that time, 1129 patients had undergone randomization at referral hospitals, and 443 patients had undergone randomization at invasive-treatment centers. Base-line characteristics of patients randomly assigned to fibrinolysis were similar to those of patients randomly assigned to angioplasty (Table 1Table 1
Base-Line Characteristics of the Patients.). Four percent of the patients screened at referral hospitals were excluded because they were judged to be unable to tolerate being transported. Detailed information on screened and excluded patients is available elsewhere.6 Time from Symptoms to Treatment
The time from the onset of symptoms to the start of treatment is shown in Table 2Table 2
Time from Onset of Symptoms to Start of Fibrinolytic or Angioplastic Treatment.. Twenty-seven percent of patients underwent randomization within one hour after onset, 31 percent between one and two hours after onset, 24 percent between two and four hours after onset, 9 percent between four and six hours after onset, and 9 percent six hours or more after onset. The median time from the onset of symptoms to randomization was 135 minutes for the total population.The median distance that patients had to be transported from a referral hospital to an invasive-treatment center was 50 km, with a range of 3 to 150 km. Thirty percent of patients who were transferred had to be transported 3 to 25 km, 34 percent 26 to 50 km, 18 percent 51 to 75 km, and 18 percent 76 to 150 km. The transfer time was defined as the time from randomization at the referral hospital to arrival in the catheterization laboratory. The median transfer time was 67 minutes (interquartile range, 50 to 85). Forty-three percent of patients who were transferred had a transfer time of less than one hour, 53 percent a transfer time of one to two hours, and 4 percent a transfer time of two to three hours.
Adverse Events during Transportation
A total of 559 of the 567 patients randomly assigned to angioplasty at referral hospitals (99 percent) were transferred. Atrial fibrillation developed in 14 patients, intermittent advanced atrioventricular block in 13 patients, and ventricular fibrillation in 8 patients. There were no deaths during transportation. One patient had refractory ventricular fibrillation on arrival at the invasive-treatment center and died one hour later after an unsuccessful attempt at resuscitation.
Immediate Treatment and Angioplasty Results
Among the 782 patients randomly assigned to fibrinolysis, 775 patients (99 percent) received the assigned treatment. Of the 790 patients randomly assigned to angioplasty, 777 patients (98 percent) underwent immediate angiography. Angioplasty was attempted in 706 patients, and balloon inflation was performed in 686 patients (87 percent of the 790 who were randomly assigned to angioplasty). Stents were implanted in 638 of these patients (93 percent), and 310 patients were treated with platelet glycoprotein IIb/IIIa–receptor blockers during catheterization. The infarct-related vessel was the left anterior descending artery in 46 percent of the patients who underwent angiographic examination, the right coronary artery in 35 percent, and the left circumflex artery in 12 percent. The remaining infarct-related vessels were minor side branches.
The flow of the presumed infarct-related artery was of TIMI grade 0 or 1 on initial angiography in 68 percent of patients, grade 2 in 14 percent of patients, and grade 3 in 18 percent of patients. The postprocedural flow was of TIMI grade 0 or 1 in 3 percent of patients, grade 2 in 15 percent, and grade 3 in 83 percent (usable angiograms were available for 699 patients). Among the patients who underwent angioplasty, a postprocedural flow of TIMI grade 0 or 1 was achieved in 2 percent, grade 2 in 16 percent, and grade 3 in 82 percent.
Of the 91 patients who underwent immediate angiography but did not undergo balloon inflation, 31 had normal coronary arteries. Among the remaining 60 patients, medical treatment was considered to be the best initial strategy for 36 patients, balloon inflation was not possible for technical reasons in 17 patients, 3 patients had chronic occlusions without a culprit lesion, and 4 patients died before angioplasty could be performed. Only one patient underwent coronary surgery immediately after the angiographic examination.
Clinical Outcome
The clinical outcomes at 30 days are shown in Table 3Table 3
Clinical Outcome at 30 Days., Figure 1Figure 1Kaplan–Meier Curves Showing Cumulative Event Rates for the Primary Composite End Point of Death, Clinical Reinfarction, or Disabling Stroke during 30 Days of Follow-up., and Figure 2Figure 2Odds Ratios for the Primary Composite End Point of Death, Reinfarction, or Disabling Stroke at 30 Days of Follow-up among All 790 Patients Randomly Assigned to Primary Angioplasty as Compared with All 782 Patients Randomly Assigned to Fibrinolysis, According to Base-Line Characteristics.. The relative reduction in the rate of the composite outcome was 40 percent among patients enrolled at referral hospitals and 45 percent among those enrolled at invasive-treatment centers. The superiority of angioplasty over fibrinolysis was driven by a 75 percent reduction in the relative risk of clinical reinfarction, whereas the reduction in the risks of death and stroke did not reach statistical significance. The number of patients who would need to be treated in order to avoid one death, clinical reinfarction, or disabling stroke in a 30-day period was 17 for referral hospitals and 18 for invasive-treatment centers. The rate of the primary composite end point was consistently lower with angioplasty than with fibrinolysis in a number of prespecified subgroups (Figure 2). No significant interactions between subgroups and treatment were detected. The relative benefit of angioplasty remained constant among the 646 patients whose symptoms had lasted less than two hours, the 549 patients whose symptoms had lasted two to four hours, and the 377 patients whose symptoms had lasted four hours or more.Among the 62 patients who had clinical reinfarction during follow-up, 30-day mortality was 24.2 percent, as compared with 6.5 percent among the remaining 1510 patients (P<0.001). Procedure-related reinfarctions occurred in 10 patients randomly assigned to fibrinolysis and 5 patients randomly assigned to angioplasty — after coronary-bypass surgery in 11 cases and after angioplasty in 4 cases. Inclusion of these procedure-related reinfarctions in the analysis of clinical reinfarctions did not change the results.
The types of medication prescribed at discharge did not differ between patients randomly assigned to angioplasty and those assigned to fibrinolysis. A total of 96 percent of patients received aspirin, 87 percent received beta-blockers, 51 percent received lipid-lowering drugs, and 36 percent received angiotensin-converting–enzyme inhibitors.
Repeated Coronary Revascularization during Follow-up
In the fibrinolysis group, 26 patients underwent repeated fibrinolysis within 12 hours after randomization, and 15 patients underwent rescue angioplasty (P=0.22). During the 30 days of follow-up, 148 patients randomly assigned to fibrinolysis underwent mechanical revascularization (coronary-bypass surgery in 20 patients and angioplasty in 129 patients), as did 72 patients randomly assigned to angioplasty (coronary-bypass surgery in 30 patients and angioplasty in 45 patients) (P<0.001 for the comparison between groups); some patients had more than one procedure.
Discussion
In a large cohort, we found that primary angioplasty is superior to fibrinolysis for patients who have myocardial infarction with ST-segment elevation, even when patients are admitted to a local hospital without angioplasty capabilities and must be transported to an invasive-treatment center. Our study demonstrates that it is possible to implement a new treatment strategy with 24-hour invasive-treatment services in a community that has not previously offered primary angioplasty as routine treatment. The benefit of treatment with primary angioplasty was the same for patients transferred from community hospitals as for patients admitted directly to an interventional-treatment center.
The transfer of patients was found to be safe. Only 4 percent of the screened patients were considered to be unable to tolerate being transported. Our results extend the findings of the recent PRAGUE-2 study.7
Our study was designed to minimize all components of the delay in treatment. At the primary admission, patients were brought directly to the coronary care unit by the ambulance staff, thus bypassing the emergency ward. Interhospital transportation was provided by the same ambulance, and the angioplasty center was alerted immediately on the initiation of transportation to ensure direct access to the catheterization room. Even with this algorithm, the median time from admission to the start of transportation was 50 minutes, which still compares favorably with the delay of approximately 75 minutes in the recent Air Primary Angioplasty in Myocardial Infarction study.8 The time required for transfer by ambulance between hospitals constituted only 14 percent of the total time between the onset of symptoms and the start of treatment, despite the fact that 70 percent of the patients were transported farther than 25 km. Almost all patients enrolled at community hospitals arrived in the catheterization laboratory within two hours after randomization. This fact makes our results applicable to most Western communities and opens the way for more widespread use of primary angioplasty in the treatment of patients who have myocardial infarction with ST-segment elevation.
Although the rates of death, clinical reinfarction, and stroke were all reduced with angioplasty, the better overall outcome after angioplasty was driven primarily by the reduction in the rate of reinfarction. Our finding of a higher 30-day mortality rate among patients with reinfarction accords with recent results by Gibson et al.9 and indicates that clinical reinfarction in our trial was a severe event. The prognostic significance of procedure-related ischemic events is uncertain.10 The inclusion in the analysis of procedure-related reinfarctions strengthened, rather than weakened, the evidence of a favorable outcome after angioplasty.
Our angiographic success rate, with the achievement of a flow of TIMI grade 3 in 83 percent of our patients, is similar to the success rates in experienced centers.11-13 It is well documented that the benefit of primary angioplasty depends on the volume of procedures performed and the level of experience of the physician.14,15 Although all five invasive-treatment centers in our study were high-volume interventional-treatment centers (performing 600 to 1600 angioplasty procedures per year), they had had limited experience in performing primary angioplasty at the beginning of the study. However, they were all able to adapt the training program and obtain and maintain the necessary skills.
The frequency of rescue angioplasty was low. Although one may argue that our approach was too conservative, there is no published evidence of a treatment benefit of rescue angioplasty in patients who have been treated with fibrinolysis at referral hospitals. At 30 days of follow-up, one fifth of the patients who had been treated with fibrinolysis had undergone ischemia-guided mechanical revascularization, in accordance with the protocol of our previous study.16
Future attempts to improve the clinical outcome associated with primary angioplasty should focus on the logistics of transferring patients and on adjunctive medication. One approach might be to obtain an electrocardiogram in the ambulance and then to transfer the patient directly to a center with facilities for primary angioplasty, with or without surgical backup.17 There has been great interest in “facilitated” angioplasty involving the use of a reduced dose of a fibrinolytic drug in combination with more aggressive antithrombotic treatment before angioplasty. Trials dealing with such strategies have not yet provided convincing evidence of their effectiveness.18
Supported by grants from the Danish Heart Foundation, the Danish Medical Research Council, AstraZeneca, Bristol-Myers Squibb, Cordis, Pfizer, Pharmacia–Upjohn, Boehringer Ingelheim, and Guerbet.
Dr. Andersen reports having received lecture fees from Eli Lilly; Dr. Nielsen lecture fees, consulting fees, or both from Bristol-Myers Squibb and Pfizer; Dr. Rasmussen lecture fees and grant support from Bristol-Myers Squibb and Cordis; and Dr. Haghfelt lecture fees, grant support, or consulting fees from Merck Sharp & Dohme, Pfizer, Aventis Pharma, and AstraZeneca.
Source Information
From the Departments of Cardiology at Skejby Hospital, Aarhus University Hospital, Aarhus (H.R.A., T.T.N., L.T., L.R.K.); Aalborg University Hospital, Aalborg (K.R., A.B.V.); Rigshospitalet University Hospital, Copenhagen (H.K., J.K.M., P.G.); Odense University Hospital, Odense (P.T., T.H.); and the Gentofte Hospital, Hellerup (U.A.); the Departments of Medicine at Hilleroed Hospital, Hilleroed (F.P.); Randers Hospital, Randers (P.L.); Aarhus County Hospital and Aarhus University Hospital, Aarhus (S.E.H.); and Horsens Hospital, Horsens (E.V.); the Department of Cardiothoracic Surgery, Gentofte Hospital, Hellerup (H.K.K.); and UNI-C, Danish Information Technology Centre for Education and Research, Aarhus (L.S.M.) — all in Denmark.
Address reprint requests to Dr. Andersen at the Department of Cardiology, Skejby Hospital, Aarhus University Hospital, DK-8200 Aarhus N, Denmark, or at henning.rud.andersen@iekf.au.dk.
Participants in the Danish Multicenter Randomized Study on Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) are listed in the Appendix.
Appendix
The following are participants in DANAMI-2. Steering Committee: T.T. Nielsen (chair), H.R. Andersen, L. Thuesen, H. Kelbaek, P. Grande, J.K. Madsen, P. Thayssen, T. Haghfelt, K. Rasmussen, T. Vesterlund, O. Amtorp, U. Abildgaard, F.H. Pedersen, K. Egstrup, and H.K. Kjaergard. End Points Committee: E. Steinmetz (chair), L.R. Krusell, K.N. Hansen, P.R. Hansen, P. Clemmensen, and I. Christiansen. Audit Committee: P. Clemmensen (chair), S. Galatius, and C. Sundgreen. Safety and Ethics Committee: H. Ibsen (chair), K. Mellemgaard (chair), S. Strandgaard, J.S. Christiansen, L.S. Mortensen, M.L. Simoons, F. Zijlstra, C.L. Grines, L. Ekström, and G.W. Stone. Participating hospitals and principal investigators (the number in parenthesis is the number of patients randomized): Aalborg University Hospital, K. Rasmussen (181), Horsens Hospital, E. Vigholt (127), Randers Hospital, P. Lomholt (117), Aarhus Amtssygehus, S. Husted (110), Bispebjerg Hospital, N. Gadsboell (88), Odense University Hospital, P. Thayssen (88), Skejby Sygehus, Aarhus University Hospital, H.R. Andersen (83), Viborg Hospital, O. Lederballe (71), Hjoerring Hospital, N. Falstie-Jensen (56), Gentofte Hospital, U. Abildgaard (51), Glostrup Hospital, J.R. Nielsen (47), Grenaa Hospital, H. Rickers (42), Skive Hospital, S.E. Stentebjerg (41), Silkeborg Hospital, F. Roemer (40), Herning Hospital, D. Dalsgaard (40), Rigshospitalet, K. Saunamäki (40), Nykoebing Mors, A.N. Davidson (38), Kolding Hospital, M. Asklund (38), Vejle Hospital, B. Engby (37), Frederiksberg Hospital, P. Hildebrandt (37), Odder Hospital, B. Jastrup (37), Amager Hospital, H. Nielsen (34), Frederikshavn Hospital, H. Sejersen (31), Hilleroed Hospital, J. Launbjerg (27), Haderslev Hospital, P. Wiggers (26), Fredericia Hospital, J. Markenvard (23), Hvidovre Hospital, S.L. Rasmussen (19), Skagen Hospital, H. Sejersen (4), and Brovst Hospital, E. Steinmetz (2). Angioplasty centers (the number in parenthesis is the number of patients treated with angioplasty): Skejby Hospital, L. Thuesen, H.R. Andersen (421), Aalborg University Hospital, K. Rasmussen, A.B. Villadsen (135), Rigshospitalet, J.K. Madsen, K. Saunamäki (108), Gentofte Hospital, U. Abildgaard, E. Kassis (63), and Odense University Hospital, P. Thayssen (55).
- References
References
1
Grines CL ,Browne KF ,Marco J , et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679
Full Text | Web of Science | Medline2
Zijlstra F ,de Boer MJ ,Hoorntje JC ,Reiffers S ,Reiber JH ,Suryapranata H . A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684
Full Text | Web of Science | Medline3
Gibbons RJ ,Holmes DR ,Reeder GS ,Bailey KR ,Hopfenspirger MR ,Gersh BJ . Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-691
Full Text | Web of Science | Medline4
Keeley EC ,Boura JA ,Grines CL . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20
CrossRef | Web of Science | Medline5
The TIMI Study Group
Web of Science | Medline6
Andersen HR ,Nielsen TT ,Vesterlund T , et al. The Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANAMI-2 trial. Am Heart J 2003;146:234-241
CrossRef | Web of Science | Medline7
Widimsky P ,Budesinsky T ,Vorac D , et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial -- PRAGUE-2. Eur Heart J 2003;24:94-104
CrossRef | Web of Science | Medline8
Grines CL ,Westerhausen DR Jr ,Grines LL , et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 2002;39:1713-1719
CrossRef | Web of Science | Medline9
Gibson M ,Murphy SA ,James D , et al. Is recurrent myocardial infarction following thrombolytic administration associated with long-term mortality? J Am Coll Cardiol 2002;39:Suppl A:280A-280A abstract.
CrossRef | Web of Science10
Fox KA ,Poole-Wilson PA ,Henderson RA , et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet 2002;360:743-751
CrossRef | Web of Science | Medline11
The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
Full Text | Web of Science | Medline12
Stone GW ,Grines CL ,Cox DA , et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966
Full Text | Web of Science | Medline13
Montalescot G ,Barragan P ,Wittenberg O , et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-1903
Full Text | Web of Science | Medline14
Magid DJ ,Calonge BN ,Rumsfeld JS , et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 2000;284:3131-3138
CrossRef | Web of Science | Medline15
Canto JG ,Every NR ,Magid DJ , et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med 2000;342:1573-1580
Full Text | Web of Science | Medline16
Madsen JK ,Grande P ,Saunamaki K , et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation 1997;96:748-755
Web of Science | Medline17
Aversano T ,Aversano LT ,Passamani E , et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002;287:1943-1951
CrossRef | Web of Science | Medline18
Bonnefoy E ,Lapostolle F ,Leizorovicz A , et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-829
CrossRef | Web of Science | Medline
- Citing Articles (315)
Citing Articles
1
S. Dharma, D. A. Juzar, I. Firdaus, S. Soerianata, A. J. Wardeh, J. W. Jukema. (2012) Acute myocardial infarction system of care in the third world. Netherlands Heart Journal
CrossRef2
Hélder Pereira. (2012) Projeto Algarve: a região mais próxima dos objetivos da iniciativa Stent for Life. Revista Portuguesa de Cardiologia
CrossRef3
Basar Candemir, Mustafa Kilickap, Ozgur Ulas Ozcan, Cansin Tulunay Kaya, Menekse Gerede, Aydan Ongun Ozdemir, Cagdas Ozdol, Deniz Kumbasar, Cetin Erol. (2012) Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction. Journal of Thrombosis and Thrombolysis
CrossRef4
S. D. Kristensen, M. Würtz, E. L. Grove, R. De Caterina, K. Huber, D. J. Moliterno, F.-J. Neumann. (2012) Contemporary use of glycoprotein IIb/IIIa inhibitors. Thrombosis and Haemostasis 107:2,
CrossRef5
J. Lonborg, H. Kelbaek, N. Vejlstrup, H. E. Botker, W. Y. Kim, L. Holmvang, E. Jorgensen, S. Helqvist, K. Saunamaki, L. Thuesen, L. R. Krusell, P. Clemmensen, T. Engstrom. (2011) Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction. European Journal of Echocardiography
CrossRef6
Lisette Okkels Jensen, Michael Maeng, Per Thayssen, Hans Henrik Tilsted, Christian Juhl Terkelsen, Anne Kaltoft, Jens Flensted Lassen, Knud Nørregaard Hansen, Jan Ravkilde, Evald Høj Christiansen, Morten Madsen, Henrik Toft Sørensen, Leif Thuesen. (2011) Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology
CrossRef7
C.H. Jørgensen, G.H. Gislason, D. Bretler, R. Sørensen, M.L. Norgaard, M.L. Hansen, T.K. Schramm, S.Z. Abildstrom, C. Torp-Pedersen, P.R. Hansen. (2011) Glyburide increases risk in patients with diabetes mellitus after emergent percutaneous intervention for myocardial infarction — A nationwide study. International Journal of Cardiology 152:3, 327-331
CrossRef8
Morten Schou, Nana Valeur, Christian Torp-Pedersen, Finn Gustafsson, Lars Køber. (2011) Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF. European Journal of Clinical Investigation 41:11, 1237-1244
CrossRef9
Eva Andrés, Alberto Cordero, Purificación Magán, Eduardo Alegría, Montserrat León, Emilio Luengo, Rosa Magallón Botaya, Luis García Ortiz, José A. Casasnovas. (2011) Mortalidad a largo plazo y reingreso hospitalario tras infarto agudo de miocardio: un estudio de seguimiento de ocho años. Revista Española de Cardiología
CrossRef10
Marco Tubaro, Nicolas Danchin, Patrick Goldstein, Gerasimos Filippatos, Yonathan Hasin, Magda Heras, Petr Jansky, Tone M. Norekval, Eva Swahn, Kristian Thygesen, Christiaan Vrints, Doron Zahger, Hans R. Arntz, Abdelouahab Bellou, Jean E. De La Coussaye, Leonardo De Luca, Kurt Huber, Yves Lambert, Maddalena Lettino, Bertil Lindahl, Scott Mclean, Lutz Nibbe, William F. Peacock, Susanna Price, Tom Quinn, Christian Spaulding, Gabriel Tatu-Chitoiu, Frans Van De Werf. (2011) Tratamiento prehospitalario de los pacientes con IAMCEST. Una declaración científica del Working Group Acute Cardiac Care de la European Society of Cardiology. Revista Española de Cardiología
CrossRef11
C. Lewinter, C. Torp-Pedersen, J. G. F. Cleland, L. Kober. (2011) Right and left bundle branch block as predictors of long-term mortality following myocardial infarction. European Journal of Heart Failure
CrossRef12
Wolfgang Scheidt, Christian Thilo. (2011) As time goes by? The fallacy of thrombolysis in STEMI networks. Clinical Research in Cardiology 100:10, 867-877
CrossRef13
Alka B. Patel, Hude Quan, Peter Faris, Merril L. Knudtson, Mouhieddin Traboulsi, Bing Li, William A. Ghali. (2011) Temporal Associations of Early Patient Transfers and Mortality With the Implementation of a Regional Myocardial Infarction Care Model. Canadian Journal of Cardiology
CrossRef14
Benoit Daneault, Doan Hoa Do, Andrée Maltais, Simon Bérubé, Richard Harvey, André Gervais, Karl Dalery, Michel Nguyen. (2011) Reduction of Delays in Primary Percutaneous Coronary Intervention. Canadian Journal of Cardiology 27:5, 562-566
CrossRef15
Kyle J. Muus, Alana D. Knudson, Marilyn G. Klug, Joshua Wynne. (2011) In-Hospital Mortality Among Rural Medicare Patients With Acute Myocardial Infarction: The Influence of Demographics, Transfer, and Health Factors. The Journal of Rural Health 27:4, 394-400
CrossRef16
Peter H. Nielsen, Christian J. Terkelsen, Torsten T. Nielsen, Leif Thuesen, Lars R. Krusell, Per Thayssen, Henning Kelbæk, Ulrik Abildgaard, Anton B. Villadsen, Henning R. Andersen, Michael Maeng. (2011) System Delay and Timing of Intervention in Acute Myocardial Infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] Trial). The American Journal of Cardiology 108:6, 776-781
CrossRef17
Minna Tahvanainen, Kjell C. Nikus, Lene Holmvang, Peter Clemmensen, Samuel Sclarovsky, Yochai Birnbaum, Henning Kelbæk, Heini Huhtala, Hans-Henrik Tilsted, Markku J. Eskola. (2011) Factors associated with failure to identify the culprit artery by the electrocardiogram in inferior ST-elevation myocardial infarction. Journal of Electrocardiology 44:5, 495-501
CrossRef18
O. Ahlehoff, G. H. Gislason, J. Lindhardsen, J. B. Olesen, M. Charlot, L. Skov, C. Torp-Pedersen, P. R. Hansen. (2011) Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study. Journal of Internal Medicine 270:3, 237-244
CrossRef19
Matthew Balerdi, Daniel Y. Ellis, Philip Grieve, Paul Murray, Miles Dalby. (2011) Aeromedical transfer to reduce delay in primary angioplasty. Resuscitation 82:7, 947-950
CrossRef20
V. J. MARDER. (2011) Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin. Journal of Thrombosis and Haemostasis 9, 364-373
CrossRef21
Yen Tibayan. 2011. ST-Elevation Myocardial Infarction. , 53-65.
CrossRef22
(2011) Acute Coronary Syndromes: Reperfusion Strategy. ARC and NZRC Guideline 2011. Emergency Medicine Australasia 23:3, 312-316
CrossRef23
M. Tubaro, N. Danchin, P. Goldstein, G. Filippatos, Y. Hasin, M. Heras, P. Jansky, T. M. Norekval, E. Swahn, K. Thygesen, C. Vrints, D. Zahger, H. R. Arntz, A. Bellou, J. E. de La Coussaye, L. de Luca, K. Huber, Y. Lambert, M. Lettino, B. Lindahl, S. McLean, L. Nibbe, W. F. Peacock, S. Price, T. Quinn, C. Spaulding, G. Tatu-Chitoiu, F. van de Werf. (2011) Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology. Acute Cardiac Care 13:2, 56-67
CrossRef24
Darren L Walters, Carol Cunningham. (2011) Managing acute coronary syndromes in the prehospital and emergency setting: New guidelines from the Australian Resuscitation Council and New Zealand Resuscitation Council. Emergency Medicine Australasia 23:3, 240-243
CrossRef25
Barbara J. Kilbourne, Robert S. Levine, Warren Lambert, Dustin Brown, Gottlieb Friesinger, Charles H. Hennekens. (2011) Geographic Variations in Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Among Tennessee Elders. Southern Medical Journal 104:6, 389-396
CrossRef26
Ivan Comelli, Luigi Vignali, Angelo Rolli, Giuseppe Lippi, Gianfranco Cervellin. (2011) Achievement of a median door-to-balloon time of less than 90 minutes by implementation of organizational changes in the ‘Emergency Department to Cath Lab’ pathway: a 5-year analysis. Journal of Evaluation in Clinical Practiceno-no
CrossRef27
Neil Swanson, Anthony Gershlick. 2011. Primary and Rescue PCI in Acute Myocardial Infarction. , 242-261.
CrossRef28
ALLAN IVERSEN, ULRIK ABILDGAARD, ANDERS GALLOE, PETER R. HANSEN, SOREN GALATIUS, JAN K. MADSEN, THOMAS ENGSTROEM, SUNE PEDERSEN, KURT S. JENSEN, JAN S. JENSEN. (2011) Intracoronary Compared to Intravenous Bolus Abciximab during Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction (STEMI) Patients Reduces 30-day Mortality and Target Vessel Revascularization: A Randomized Trial. Journal of Interventional Cardiology 24:2, 105-111
CrossRef29
Marc C. Newell, Jason T. Henry, Timothy D. Henry, Sue Duval, Joseph A. Browning, Ellen C. Christiansen, David M. Larson, Alan K. Berger. (2011) Impact of age on treatment and outcomes in ST-elevation myocardial infarction. American Heart Journal 161:4, 664-672
CrossRef30
Suzanne J. Baron, Robert P. Giugliano. (2011) Effectiveness and Safety of Percutaneous Coronary Intervention After Fibrinolytic Therapy for ST-Segment Elevation Acute Myocardial Infarction. The American Journal of Cardiology 107:7, 1001-1009
CrossRef31
John A Dodson, Mathew S Maurer. (2011) Changing nature of cardiac interventions in older adults. Aging Health 7:2, 283-295
CrossRef32
Marcin Sadowski, Mariusz Gasior, Marek Gierlotka, Marianna Janion, Lech Polonski. (2011) Gender-related differences in mortality after ST-segment elevation myocardial infarction: a large multicentre national registry. EuroIntervention 6:9, 1068-1072
CrossRef33
Morten V. Sørensen, Sune Pedersen, Rasmus Møgelvang, Jan Skov-Jensen, Allan Flyvbjerg. (2011) Plasma High-Mobility Group Box 1 Levels Predict Mortality After ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 4:3, 281-286
CrossRef34
P. Lebiedz, R. Radke, A. Bohn, E. Hilker, C. Vahlhaus. (2011) Präklinische Strategien zur Optimierung der Behandlung von Patienten mit ST-Hebungsinfarkten. Intensivmedizin und Notfallmedizin 48:2, 130-134
CrossRef35
Christoph Liebetrau, Sebastian Szardien, Johannes Rixe, Mariella Woelken, Andreas Rolf, Timm Bauer, Holger Nef, Helge Möllmann, Christian Hamm, Michael Weber. (2011) Direct admission versus transfer of AMI patients for primary PCI. Clinical Research in Cardiology 100:3, 217-225
CrossRef36
Kashina Dawkins, Martin Busk, Jacob Sorensen, Leif S. Mortensen, Chuck Maynard, Sandra S. Stinnett, Galen S. Wagner, Henning R. Andersen. (2011) Association between ST segment Resolution following Fibrinolytic therapy or Intracoronary stenting, and Reinfarction in the same myocardial region in the DANAMI-2 study population. Cardiovascular Revascularization Medicine 12:2, 75-81
CrossRef37
Tzu-Hsien Tsai, Sarah Chua, Hisham Hussein, Steve Leu, Chiung-Jen Wu, Chi-Ling Hang, Hsiu-Yu Fang, Sheng-Ying Chung, Morgan Fu, Huang-Chung Chen, Li-Teh Chang, Kuo-Ho Yeh, Hon-Kan Yip. (2011) Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention*. Critical Care Medicine 39:3, 436-442
CrossRef38
P. Widimsky, D. R. Holmes. (2011) How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?. European Heart Journal 32:4, 396-403
CrossRef39
J. J. Thune, J. E. Signorovitch, L. Kober, J. J. V. McMurray, K. Swedberg, J. Rouleau, A. Maggioni, E. Velazquez, R. Califf, M. A. Pfeffer, S. D. Solomon. (2011) Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. European Journal of Heart Failure 13:2, 148-153
CrossRef40
Sonja Postma, Jan-Henk E. Dambrink, Menko-Jan de Boer, A.T. Marcel Gosselink, Gerrit J. Eggink, Henri van de Wetering, Frans Hollak, Jan Paul Ottervanger, Jan C.A. Hoorntje, Evelien Kolkman, Harry Suryapranata, Arnoud W.J. van 't Hof. (2011) Prehospital triage in the ambulance reduces infarct size and improves clinical outcome. American Heart Journal 161:2, 276-282
CrossRef41
Giuseppe Tarantini, Frans Van de Werf, Claudio Bilato, Bernard Gersh. (2011) Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait?. American Heart Journal 161:2, 247-253
CrossRef42
Sanjeev U. Nair, Justin B. Lundbye. (2011) The Use of Hypothermia Therapy in Cardiac Arrest Survivors. Therapeutic Hypothermia and Temperature Management 1:1, 9-21
CrossRef43
Zuzana Kaifoszova, Petr Widimsky, Steen D. Kristensen. (2011) La iniciativa Stent for Life en Europa. Revista Española de Cardiología Suplementos 11, 2-5
CrossRef44
Soo Kim, Sang Oh, Seung Choi, Kyu Park, Young Kim, Chun Youn. (2011) The appropriateness of single page of activation of the cardiac catheterization laboratory by emergency physician for patients with suspected ST-segment elevation myocardial infarction: a cohort study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 19:1, 50
CrossRef45
Vicente Peral, Andrés Carrillo, Armando Bethencourt, Miguel Fiol, Alfredo Gómez-Jaume, Mar Alameda, Marcos Pascual, Carlos Fernández-Palomeque, Catalina Rubert, Lorenzo Socías. (2011) Modelo de intervención coronaria percutánea primaria en las Islas Baleares. Revista Española de Cardiología Suplementos 11, 35-43
CrossRef46
Andrés Íñiguez Romo, Nicolás Vázquez González, Ramiro Trillo Nouche, José Antonio Baz, José Manuel Vázquez, Alfonso Castro Beiras, Antonio Amaro Cendón, José Ramón González Juanatey, Francisco Calvo Iglesias, M. Victoria Barreiro Díaz, Luisa Chayán Zas, Jorge Puente Hernández, Jacobo Varela-Portas Mariño, José Ramón Gómez Fernández. (2011) Modelo de intervención coronaria percutánea primaria en la Comunidad de Galicia. Revista Española de Cardiología Suplementos 11, 44-50
CrossRef47
Ralf Birkemeyer, Andreas Rillig, Annette Koch, Tomislav Miljak, Markus Kunze, Udo Meyerfeldt, Wolfgang Steffen, Martin Soballa, Carsten Ranke, Roland Prassler, Albert Benzing, Werner Jung. (2010) Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network. Clinical Research in Cardiology 99:12, 833-840
CrossRef48
Aaron L. Doonan, Marc C. Newell, David M. Larson, Timothy D. Henry. (2010) Pharmaco-invasive Strategies Expand Access to Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction. Progress in Cardiovascular Diseases 53:3, 188-194
CrossRef49
Peter Clemmensen, Søren Loumann-Nielsen, Maria Sejersten. (2010) Telemedicine fighting acute coronary syndromes. Journal of Electrocardiology 43:6, 615-618
CrossRef50
Jochen Wöhrle, Martin Desaga, Chris Metzger, Kurt Huber, Harry Suryapranata, Victor Guetta, Giulio Guagliumi, Bernhard Witzenbichler, Helen Parise, Roxana Mehran, Gregg W. Stone. (2010) Impact of Transfer for Primary Percutaneous Coronary Intervention on Survival and Clinical Outcomes (from the HORIZONS-AMI Trial). The American Journal of Cardiology 106:9, 1218-1224
CrossRef51
Kenneth Morgan, Marie Leahy, Jeremy Butts, Kevin Beatt. (2010) The cost effectiveness of primary angioplasty compared to thrombolysis in the real world: one year results from West London. EuroIntervention 6:5, 596-603
CrossRef52
Fausan S Tsai, William M Mellana, Wilbert S Aronow, Chul Ahn, Ambra Ferraris, Majid Dudha, Kumar Kalapatapu, Anthony L Pucillo, Craig E Monsen. (2010) Interhospital Transfer of Patients With ST-Segment Elevation Myocardial Infarction for Percutaneous Coronary Intervention. American Journal of Therapeutics 17:6, e189-e192
CrossRef53
Martin Kreutzer, Anders Magnuson, Bo Lagerqvist, Ole Fröbert. (2010) Patent coronary artery and myocardial infarction in the era of primary angioplasty: assessment of an old problem in a new setting with data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention 6:5, 590-595
CrossRef54
V. Raj, K. Karunasaagarar, J.H.F. Rudd, N. Screaton, D. Gopalan. (2010) Complications of myocardial infarction on multidetector-row computed tomography of chest. Clinical Radiology 65:11, 930-936
CrossRef55
Michel R. Le May, Richard Dionne, Justin Maloney, Pierre Poirier. (2010) The Role of Paramedics in a Primary PCI Program for ST-Elevation Myocardial Infarction. Progress in Cardiovascular Diseases 53:3, 183-187
CrossRef56
Davide Capodanno, Dominick J. Angiolillo. (2010) Antithrombotic Therapy in the Elderly. Journal of the American College of Cardiology 56:21, 1683-1692
CrossRef57
Michael M. Hirschl, Harald Mayr, Friedrich Erhart, Walter Brunner, Friedrich Steger, Martin Gattermeier, Franz Pfeffel. (2010) Prehospital treatment of patients with acute myocardial infarction with bivalirudin
. The American Journal of Emergency Medicine
CrossRef58
Jasmeet Soar, Mary E. Mancini, Farhan Bhanji, John E. Billi, Jennifer Dennett, Judith Finn, Matthew Huei-Ming Ma, Gavin D. Perkins, David L. Rodgers, Mary Fran Hazinski, Ian Jacobs, Peter T. Morley. (2010) Part 12: Education, implementation, and teams. Resuscitation 81:1, e288-e332
CrossRef59
Rob Adams, Yolande Appelman, Jean G. Bronzwaer, Ton Slagboom, Giovanni Amoroso, Pieternel van Exter, G.P. Jan Tijssen, Robbert J. de Winter. (2010) Implementation of a Prehospital Triage System for Patients With Chest Pain and Logistics for Primary Percutaneous Coronary Intervention in the Region of Amsterdam, The Netherlands. The American Journal of Cardiology 106:7, 931-935
CrossRef60
Leo Bossaert, Robert E. O’Connor, Hans-Richard Arntz, Steven C. Brooks, Deborah Diercks, Gilson Feitosa-Filho, Jerry P. Nolan, Terry L. Vanden Hoek, Darren L. Walters, Aaron Wong, Michelle Welsford, Karen Woolfrey. (2010) Part 9: Acute coronary syndromes. Resuscitation 81:1, e175-e212
CrossRef61
Francesco Prati, Davide Capodanno, Tomasz Pawlowski, Vito Ramazzotti, Mario Albertucci, Alessio La Manna, Marilena Di Salvo, Robert J. Gil, Corrado Tamburino. (2010) Local Delivery Versus Intracoronary Infusion of Abciximab in Patients With Acute Coronary Syndromes. JACC: Cardiovascular Interventions 3:9, 928-934
CrossRef62
Hedvig Andersson, Maria Sejersten, Peter Clemmensen, Peer Grande. (2010) Prognosis and high-risk complication identification in unselected patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Acute Cardiac Care 12:3, 102-108
CrossRef63
Rajendra H. Mehta, Anita Y. Chen, E. Magnus Ohman, W. Brian Gibler, Eric D. Peterson, Matthew T. Roe. (2010) Influence of transfer-in rates on quality of care and outcomes at receiving hospitals in patients with non–ST-segment elevation myocardial infarction. American Heart Journal 160:3, 405-411
CrossRef64
Chu-Lin Tsai, David J. Magid, Ashley F. Sullivan, James A. Gordon, Rainu Kaushal, P. Michael Ho, Pamela N. Peterson, David Blumenthal, Carlos A. Camargo. (2010) Quality of Care for Acute Myocardial Infarction in 58 U.S. Emergency Departments. Academic Emergency Medicine 17:9, 940-950
CrossRef65
M. L. Norgaard, S. S. Andersen, T. K. Schramm, F. Folke, C. H. Jørgensen, M. L. Hansen, C. Andersson, D. M. Bretler, A. Vaag, L. Køber, C. Torp-Pedersen, G. H. Gislason. (2010) Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study. Diabetologia 53:8, 1612-1619
CrossRef66
Michael C Reed, Brahmajee K Nallamothu. (2010) Optimizing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Interventional Cardiology 2:4, 449-453
CrossRef67
Rodrigo Estévez-Loureiro, Ramon Calviño-Santos, Jose-Manuel Vázquez-Rodríguez, Raquel Marzoa-Rivas, Eduardo Barge-Caballero, Jorge Salgado-Fernández, Guillermo Aldama-López, Maria Barreiro-Díaz, Jacobo Varela-Portas, Miguel Freire-Tellado, Nicolas Vázquez-González, Alfonso Castro-Beiras. (2010) Direct transfer of ST-elevation myocardial infarction patients for primary percutaneous coronary intervention from short and long transfer distances decreases temporal delays and improves short-term prognosis: the PROGALIAM Registry. EuroIntervention 6:3, 343-349
CrossRef68
Frans Van de Werf. (2010) Acute coronary syndromes: Transport for PCI versus fibrinolysis—long-term data scrutinized. Nature Reviews Cardiology 7:8, 419-420
CrossRef69
Ertugrul Okuyan, Ahmet Uslu, Mustafa O. Levent, Irfan Sahin, Mustafa H. Dinckal. (2010) Caring of ST-elevation myocardial infarction patients in rural community hospital settings: Determinants of in-hospital mortality. Australian Journal of Rural Health 18:4, 173-178
CrossRef70
Alex Hobson, Nick Curzen. 2010. Acute Coronary Syndromes and Myocardial Infarction. , 234-255.
CrossRef71
(2010) CardioPulse Articles * Cardiology in Brazil: a country in development * Climbing the academic ladder in cardiology: Italy * Should the rebellious Danes stay with the balloons or should they adhere to the 2008 ESC ST-elevation myocardial infarction guidelines and re-introduce the lytics? * 'Soldier's heart': physiological or psychological?. European Heart Journal 31:13, 1541-1547
CrossRef72
Søren Hjortshøj, Claus Dethlefsen, Søren Risom Kristensen, Jan Ravkilde. (2010) Determinants of the release pattern of ischaemia-modified albumin in acute ST-elevation myocardial infarction treated with primary PCI. Scandinavian Journal of Clinical & Laboratory Investigation 70:4, 244-251
CrossRef73
Hendrik-Jan Dieker, Stephan S.B. Liem, Hamza El Aidi, Pierre van Grunsven, Wim R.M. Aengevaeren, Marc A. Brouwer, Freek W.A. Verheugt. (2010) Pre-Hospital Triage for Primary Angioplasty. JACC: Cardiovascular Interventions 3:7, 705-711
CrossRef74
F. A. Spencer, G. Montalescot, K. A. A. Fox, S. G. Goodman, C. B. Granger, R. J. Goldberg, G. B. F. Oliveira, F. A. Anderson, K. A. Eagle, G. Fitzgerald, J. M. Gore, . (2010) Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. European Heart Journal 31:11, 1328-1336
CrossRef75
Klaus F. Kofoed, Jan K. Madsen, Peer Grande, Kari Saunamäki, Torsten Toftegård Nielsen, Eli Kassis, Per Thayssen, Klaus Rasmussen. (2010) Long-term effects of invasive treatment in patients with a post-thrombolytic Q-wave myocardial infarction. Scandinavian Cardiovascular Journal 44:3, 146-152
CrossRef76
Graham Nichol, Jasmeet Soar. (2010) Regional cardiac resuscitation systems of care. Current Opinion in Critical Care 16:3, 223-230
CrossRef77
Vjeran Nikolić Heitzler, Zdravko Babic, Davor Milicic, Mijo Bergovec, Miroslav Raguz, Jure Mirat, Maja Strozzi, Zeljko Plazonic, Lovel Giunio, Robert Steiner, Boris Starcevic, Ivica Vukovic. (2010) Results of the Croatian Primary Percutaneous Coronary Intervention Network for Patients With ST-Segment Elevation Acute Myocardial Infarction. The American Journal of Cardiology 105:9, 1261-1267
CrossRef78
Scott T. Youngquist, Scott E. McIntosh, Eric R. Swanson, Erik D. Barton. (2010) Air Ambulance Transport Times and Advanced Cardiac Life Support Interventions during the Interfacility Transfer of Patients with Acute ST-segment Elevation Myocardial Infarction. Prehospital Emergency Care 14:3, 292-299
CrossRef79
P. Widimsky, W. Wijns, J. Fajadet, M. de Belder, J. Knot, L. Aaberge, G. Andrikopoulos, J. A. Baz, A. Betriu, M. Claeys, N. Danchin, S. Djambazov, P. Erne, J. Hartikainen, K. Huber, P. Kala, M. Klinceva, S. D. Kristensen, P. Ludman, J. M. Ferre, B. Merkely, D. Milicic, J. Morais, M. Noc, G. Opolski, M. Ostojic, D. Radovanovic, S. De Servi, U. Stenestrand, M. Studencan, M. Tubaro, Z. Vasiljevic, F. Weidinger, A. Witkowski, U. Zeymer, . (2010) Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. European Heart Journal 31:8, 943-957
CrossRef80
LOUISE J. N. JENSEN, SUNE PEDERSEN, METTE BJERRE, RASMUS MOGELVANG, JAN SKOV JENSEN, ALLAN FLYVBJERG. (2010) Plasma Calprotectin Predicts Mortality in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention. Journal of Interventional Cardiology 23:2, 123-129
CrossRef81
Sanneke P.M. de Boer, Cynthia M. Westerhout, R. John Simes, Christopher B. Granger, Felix Zijlstra, Eric Boersma. (2010) Mortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's Age. JACC: Cardiovascular Interventions 3:3, 324-331
CrossRef82
Abhimanyu Beri, Mary Printz, Ansar Hassan, Joseph D. Babb. (2010) Fibrinolysis Versus Primary Percutaneous Intervention in ST-elevation Myocardial Infarction With Long Interhospital Transfer Distances. Clinical Cardiology 33:3, 162-167
CrossRef83
Dariusz Dudek, Artur Dziewierz, Zbigniew Siudak, Tomasz Rakowski, Jaroslaw Zalewski, Jacek Legutko, Waldemar Mielecki, Marianna Janion, Stanislaw Bartus, Marcin Kuta, Lukasz Rzeszutko, Giuseppe De Luca, Krzysztof Zmudka, Jacek S. Dubiel. (2010) Transportation with very long transfer delays (>90 min) for facilitated PCI with reduced-dose fibrinolysis in patients with ST-segment elevation myocardial infarction. International Journal of Cardiology 139:3, 218-227
CrossRef84
Michael Koutouzis, Lars Grip, Göran Matejka, Per Albertsson. (2010) Primary Percutaneous Coronary Interventions in Nonagenarians. Clinical Cardiology 33:3, 157-161
CrossRef85
Hans Erik Bøtker, Rajesh Kharbanda, Michael R Schmidt, Morten Bøttcher, Anne K Kaltoft, Christian J Terkelsen, Kim Munk, Niels H Andersen, Troels M Hansen, Sven Trautner, Jens Flensted Lassen, Evald Høj Christiansen, Lars R Krusell, Steen D Kristensen, Leif Thuesen, Søren S Nielsen, Michael Rehling, Henrik Toft Sørensen, Andrew N Redington, Torsten T Nielsen. (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. The Lancet 375:9716, 727-734
CrossRef86
Pierre-Frédéric Keller, Marco Roffi. 2010. Acute Coronary Syndromes. , 1-22.
CrossRef87
Derek Y.F. So, Andrew C.T. Ha, Richard F. Davies, Michael Froeschl, George A. Wells, Michel R. Le May. (2010) ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial. Canadian Journal of Cardiology 26:1, e7-e12
CrossRef88
Young-Jo Kim. (2010) Reperfusion Strategies in Acute ST-segment Elevation Myocardial Infarction. Journal of the Korean Medical Association 53:3, 196
CrossRef89
Allen Jeremias, Sujethra Vasu, Luis Gruberg, Adnan Kastrati, Gregg W. Stone, David L. Brown. (2010) Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef90
Erlend Aune, Knut Endresen, Keith A.A. Fox, Jon Erik Steen-Hansen, Jo Roislien, Joran Hjelmesaeth, Jan Erik Otterstad. (2010) Effect of Implementing Routine Early Invasive Strategy on One-Year Mortality in Patients With Acute Myocardial Infarction. The American Journal of Cardiology 105:1, 36-42
CrossRef91
Hanne Beltesbrekke, Mari Husa, Harald Vik-Mo. (2010) Akutt hjerteinfarkt i Midt-Norge – transport for primær PCI-behandling eller trombolyse?. Tidsskrift for Den norske legeforening 130:17, 1714-1716
CrossRef92
Hiroto Shiraki, Hitoshi Yokozuka, Koji Negishi, Sousin Inoue, Tetsuo Takahashi, Masao Chino, Satoshi Ogawa. (2010) Acute Impact of Right Ventricular Infarction on Early Hemodynamic Course After Inferior Myocardial Infarction. Circulation Journal 74:1, 148-155
CrossRef93
Kurt M Reinhart, C. Michael White, William L Baker. (2009) Prasugrel: A Critical Comparison with Clopidogrel. Pharmacotherapy 29:12, 1441-1451
CrossRef94
Shoei-Shen Wang, Nai-Kuan Chou, Tze-Wen Chung. (2009) The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: An in vitro thrombolysis study. Journal of Biomedical Materials Research Part A 91A:3, 753-761
CrossRef95
Sune H. Pedersen, Soren Galatius, Peter R. Hansen, Rasmus Mogelvang, Steen Z. Abildstrom, Rikke Sørensen, Ulla Davidsen, Anders Galloe, Ulrik Abildgaard, Allan Iversen, Jan Bech, Jan K. Madsen, Jan S. Jensen. (2009) Field Triage Reduces Treatment Delay and Improves Long-Term Clinical Outcome in Patients With Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology 54:24, 2296-2302
CrossRef96
Chad S. Kessler, Evie G. Marcolini, Gillian Schmitz, Charles J. Gerardo, Glenn Burns, Brian DelliGatti, Catherine A. Marco, David E. Manthey, Deborah Gutman, Kathleen Jobe, Bradley N. Younggren, Ted Stettner, Peter E. Sokolove. (2009) Off-service Resident Education in the Emergency Department: Outline of a National Standardized Curriculum. Academic Emergency Medicine 16:12, 1325-1330
CrossRef97
Rodrigo Estévez-Loureiro, Ramón Calviño-Santos, José Manuel Vázquez, Eduardo Barge-Caballero, Jorge Salgado-Fernández, Miriam Piñeiro, Miguel Freire-Tellado, Jacobo Varela-Portas, Luisa Martínez, Sandra Gómez, José Ángel Rodríguez, Nicolás Vázquez, Alfonso Castro-Beiras. (2009) Seguridad y viabilidad del retorno precoz de pacientes transferidos para angioplastia primaria a sus centros de origen. Revista Española de Cardiología 62:12, 1356-1364
CrossRef98
G. Tarantini, R. Razzolini, M. Napodano, C. Bilato, A. Ramondo, S. Iliceto. (2009) Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. European Heart Journal
CrossRef99
A. Hvelplund, S. Galatius, M. Madsen, J. N. Rasmussen, S. Rasmussen, J. K. Madsen, N. P.R. Sand, H.-H. Tilsted, P. Thayssen, E. Sindby, S. Hojbjerg, S. Z. Abildstrom. (2009) Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. European Heart Journal
CrossRef100
Mitchell W. Krucoff. (2009) From ST-elevation myocardial infarction to ST elevation with no myocardial infarction—review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices. Journal of Electrocardiology 42:6, 487-493
CrossRef101
Alexis Matteau, Stéphane Rinfret, Marc Dorais, Jacques LeLorier, François Reeves. (2009) The safety and feasibility of immediately returning patients transferred for primary percutaneous coronary intervention with ST-elevation myocardial infarction. EuroIntervention 5:5, 599-603
CrossRef102
Surinder P. Janda, Nicholas Tan. (2009) Thrombolysis versus primary percutaneous coronary intervention for ST elevation myocardial infarctions at Chilliwack General Hospital. Canadian Journal of Cardiology 25:11, e382-e384
CrossRef103
Miles Dalby, Rajesh Kharbanda, Gopal Ghimire, Jon Spiro, Phil Moore, Michael Roughton, Rebecca Lane, Mohammad Al-Obaidi, Molly Teoh, Elizabeth Hutchison, Mark Whitbread, David Fountain, Richard Grocott-Mason, Andrew Mitchell, Mark Mason, Charles Ilsley. (2009) Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access. American Heart Journal 158:5, 829-835
CrossRef104
Maria Sejersten, Nana Valeur, Peer Grande, Torsten Toftegaard Nielsen, Peter Clemmensen. (2009) Long-Term Prognostic Value of ST-Segment Resolution in Patients Treated With Fibrinolysis or Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology 54:19, 1763-1769
CrossRef105
Patrick Goldstein, Frederic Lapostolle, Gabriel Steg, Nicolas Danchin, Nathalie Assez, Gilles Montalescot, Sandrine Charpentier, Eric Wiel, Jean Michel Juliard. (2009) Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies. European Journal of Emergency Medicine 16:5, 244-255
CrossRef106
Mohammed-Reza Movahed, Jooby John, Mehrnoosh Hashemzadeh, M. Mazen Jamal, Mehrtash Hashemzadeh. (2009) Trends in the Age Adjusted Mortality from Acute ST Segment Elevation Myocardial Infarction in the United States (1988–2004) Based on Race, Gender, Infarct Location and Comorbidities. The American Journal of Cardiology 104:8, 1030-1034
CrossRef107
Lajos Nagy, Judit Novák, Dénes Csonka. (2009) ST-elevációval járó akut szívizominfarktus miatt kórházba felvett betegek halálozása a szívkatéteres labor megnyitása előtt és után Szombathely városban. Orvosi Hetilap 150:43, 1973-1977
CrossRef108
Christoph J. Jensen, Dominik Bleckmann, Holger C. Eberle, Kai Nassenstein, Thomas Schlosser, Georg V. Sabin, Christoph K. Naber, Oliver Bruder. (2009) A simple MR algorithm for estimation of myocardial salvage following acute ST segment elevation myocardial infarction. Clinical Research in Cardiology 98:10, 651-656
CrossRef109
Nicolas Danchin. (2009) Systems of Care for ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 2:10, 901-908
CrossRef110
Alexis Matteau, Marc Dorais, Stéphane Rinfret, Jacques LeLorier, François Reeves. (2009) Effectiveness of a change in reperfusion strategy to primary percutaneous coronary intervention in a nonselected population. Canadian Journal of Cardiology 25:8, e279-e283
CrossRef111
Ekrem Yeter, Ali E Denktas. (2009) Prehospital fibrinolytic therapy followed by urgent percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Future Cardiology 5:4, 403-411
CrossRef112
Renato Valenti, Emilio Vincenzo Dovellini, Giovanni Maria Santoro. 2009. Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in the “Real World”. , 201-210.
CrossRef113
Martin Busk, Michael Maeng, Steen D. Kristensen, Leif Thuesen, Lars R. Krusell, Leif S. Mortensen, Ebbe R. Steinmetz, Torsten T. Nielsen, Henning R. Andersen. (2009) Timing, Causes, and Predictors of Death After Three Years' Follow-Up in the Danish Multicenter Randomized Study of Fibrinolysis Versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) Trial. The American Journal of Cardiology 104:2, 210-215
CrossRef114
Giuseppe De Luca, Ettore Cassetti, Paolo Marino. (2009) Percutaneous coronary intervention–related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. The American Journal of Emergency Medicine 27:6, 712-719
CrossRef115
E. Bonnefoy, P. G. Steg, F. Boutitie, P.-Y. Dubien, F. Lapostolle, J. Roncalli, F. Dissait, G. Vanzetto, A. Leizorowicz, G. Kirkorian, . (2009) Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. European Heart Journal 30:13, 1598-1606
CrossRef116
Derek P Chew, Lucy JH Blows. (2009) Randomized trials of clinical networks in the management of ST-elevation MI: can they be performed?. Current Opinion in Cardiology 24:4, 301-306
CrossRef117
Guido Parodi. 2009. Rescue and Facilitated Percutaneous Coronary Interventions. , 211-218.
CrossRef118
Judd E. Hollander, C. Michael Gibson, Charles V. Pollack. (2009) Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes. The American Journal of Emergency Medicine 27:5, 595-606
CrossRef119
M. Busk, A. Kaltoft, S. S. Nielsen, M. Bottcher, M. Rehling, L. Thuesen, H. E. Botker, J. F. Lassen, E. H. Christiansen, L. R. Krusell, H. R. Andersen, T. T. Nielsen, S. D. Kristensen. (2009) Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. European Heart Journal 30:11, 1322-1330
CrossRef120
N. Danchin, R. Carda, A. Chaib, A. Lepillier, E. Durand. (2009) Optimizing outcomes in patients with STEMI: mortality, bleeding, door-to-balloon times, and guidelines: the approach to regional systems for STEMI care: defining the ideal approach to reperfusion therapy based on recent trials. European Heart Journal Supplements 11:Suppl C, C25-C30
CrossRef121
Cedric Goldenstedt, Alain Birer, Dominique Cathignol, Cyril Lafon. (2009) Blood Clot Disruption in vitro Using Shockwaves Delivered by an Extracorporeal Generator after Pre-Exposure to Lytic Agent. Ultrasound in Medicine & Biology 35:6, 985-990
CrossRef122
Guglielmo Bernardi, Antonio Di Chiara, Ilaria Armellini. (2009) The Acute Myocardial Infarction with ST Segment Elevation Udine Registry (Come-to-Udine): predictors of 3 years mortality. Journal of Cardiovascular Medicine 10:6, 474-484
CrossRef123
Ralf Zahn, Uwe Zeymer. (2009) Akuter Myokardinfarkt: Akut-PCI in jedem Krankenhaus versus Akut-PCI im spezialisierten Zentrum. Herz Kardiovaskuläre Erkrankungen 34:3, 211-217
CrossRef124
Søren Hjortshøj, Claus Dethlefsen, Søren Risom Kristensen, Jan Ravkilde. (2009) Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia. Clinica Chimica Acta 403:1-2, 114-120
CrossRef125
H. Thiele. (2009) Optimales prähospitales Management des ST-Strecken-Hebungsinfarktes. Clinical Research in Cardiology Supplements 4:S2, 142-149
CrossRef126
Nicolas Meneveau, Marie France Séronde, Vincent Descotes-Genon, Joanna Dutheil, Romain Chopard, Fiona Ecarnot, Florent Briand, Yvette Bernard, François Schiele, Jean-Pierre Bassand. (2009) Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction patients. Clinical Research in Cardiology 98:4, 257-264
CrossRef127
Uwe Zeymer, Hans-Richard Arntz, Burkhardt Dirks, Klaus Ellinger, Harald Genzwürker, Lutz Nibbe, Ulrich Tebbe, Jochen Senges, Steffen Schneider. (2009) Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: Results of the German Prehospital Myocardial Infarction Registry (PREMIR). Resuscitation 80:4, 402-406
CrossRef128
Yi Luo, Guang-Lian Li, Yi-Zhi Pan, Shu-Feng Zhou. (2009) Determinants and Prognostic Implications of Reperfusion Injury During Primary Percutaneous Coronary Intervention in Chinese Patients with Acute Myocardial Infarction. Clinical Cardiology 32:3, 148-153
CrossRef129
Pow-Li Chia, Brian-Chung-Hoe Khoo, Chee-Keong Ng, Jimmy-Tien-Wei Lim. (2009) Primary percutaneous coronary intervention for acute myocardial infarction secondary to acute left main coronary occlusion in an institution without on-site cardiothoracic surgical support. EuroIntervention 4:5, 617-619
CrossRef130
Oliver Koeth, Timm Bauer, Harm Wienbergen, Anselm Kai Gitt, Claus Juenger, Uwe Zeymer, Karl Eugen Hauptmann, Hans Georg Glunz, Udo Sechtem, Jochen Senges, Ralf Zahn, . (2009) Angioplasty within 24 h after thrombolysis in patients with acute ST-elevation myocardial infarction: current use, predictors and outcome. Clinical Research in Cardiology 98:2, 107-113
CrossRef131
Paul Knaapen, Maarten Mulder, Friso M. Zant, Hans O. Peels, Jos W. R. Twisk, Albert C. Rossum, Jan H. Cornel, Victor A. W. M. Umans. (2009) Infarct size in primary angioplasty without on-site cardiac surgical backup versus transferal to a tertiary center: a single photon emission computed tomography study. European Journal of Nuclear Medicine and Molecular Imaging 36:2, 237-243
CrossRef132
Marc Eckstein, William Koenig, Amy Kaji, Richard Tadeo. (2009) Implementation of Specialty Centers for Patients with ST-Segment Elevation Myocardial Infarction. Prehospital Emergency Care 13:2, 215-222
CrossRef133
CINDY L. GRINES, TERESA R. NELSON, ROBERT D. SAFIAN, GEORGE HANZEL, JAMES A. GOLDSTEIN, SIMON DIXON. (2008) A Bayesian Meta-Analysis Comparing AngioJet ® Thrombectomy to Percutaneous Coronary Intervention Alone in Acute Myocardial Infarction. Journal of Interventional Cardiology 21:6, 459-482
CrossRef134
C. Michael Gibson, Yuri B. Pride, Paul D. Frederick, Charles V. Pollack, John G. Canto, Alan J. Tiefenbrunn, W. Douglas Weaver, Costas T. Lambrew, William J. French, Eric D. Peterson, William J. Rogers. (2008) Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. American Heart Journal 156:6, 1035-1044
CrossRef135
Brent C. Pottenger, Deborah B. Diercks, Deepak L. Bhatt. (2008) Regionalization of Care for ST-Segment Elevation Myocardial Infarction: Is It Too Soon?. Annals of Emergency Medicine 52:6, 677-685.e1
CrossRef136
Giuseppe De Luca, Giuseppe Biondi-Zoccai, Paolo Marino. (2008) Transferring Patients With ST-Segment Elevation Myocardial Infarction for Mechanical Reperfusion: A Meta-Regression Analysis of Randomized Trials. Annals of Emergency Medicine 52:6, 665-676
CrossRef137
Juan C. Garcia-Rubira, Rafael Garcia-Borbolla, Ivan Nuñez-Gil, Maria C. Manzano, Maria M. Garcia-Romero, Antonio Fernandez-Ortiz, Leopoldo Perez de Isla, Carlos Macaya. (2008) Distortion of the terminal portion of the QRS is predictor of shock after primary percutaneous coronary intervention for acute myocardial infarction. International Journal of Cardiology 130:2, 241-245
CrossRef138
Gabriele Giuliani, Francesco Bonechi, Sabine Vecchio, Giuseppe Biondi-Zoccai, Massimiliano Nieri, Guido Vittori, Gaia Spaziani, Franco Nassi, Tania Chechi, Carlo Di Mario, Andrea Zipoli, Massimo Margheri. (2008) Comparison of primary angioplasty in rural and metropolitan areas within an integrated network. EuroIntervention 4:3, 365-372
CrossRef139
Tamer A Elbayoumi, Vladimir P Torchilin. (2008) Liposomes for targeted delivery of antithrombotic drugs. Expert Opinion on Drug Delivery 5:11, 1185-1198
CrossRef140
Grigorios Korosoglou, Andreas Haars, Per M. Humpert, Stefan Hardt, Raffi Bekeredjian, Evangelos Giannitsis, Helmut Kuecherer, Hugo A. Katus. (2008) Evaluation of myocardial perfusion and deformation in patients with acute myocardial infarction treated with primary angioplasty and stent placement. Coronary Artery Disease 19:7, 497-506
CrossRef141
N. Danchin, E. Durand, D. Blanchard. (2008) Pre-hospital thrombolysis in perspective. European Heart Journal 29:23, 2835-2842
CrossRef142
Charles V. Pollack, Elliott M. Antman, Judd E. Hollander. (2008) 2007 Focused Update to the ACC/AHA Guidelines for the Management of Patients With ST-Segment Elevation Myocardial Infarction: Implications for Emergency Department Practice. Annals of Emergency Medicine 52:4, 344-355.e1
CrossRef143
Elliott M. Antman. (2008) Time Is Muscle. Journal of the American College of Cardiology 52:15, 1216-1221
CrossRef144
Luisa Salido, José Luis Mestre, Jaime Pey, Francisco Barcia, Enrique Asín. (2008) Análisis de mortalidad en el infarto de miocardio tratado con angioplastia primaria. Medicina Clínica 131:13, 481-486
CrossRef145
Christophe Sierro, Alexandre Berger, Eric Eeckhout, Pierre Vogt. (2008) Emergency percutaneous coronary interventions for acute myocardial infarction with ST-segment elevation in a regional hospital: A quality control study. International Journal of Cardiology 129:1, 100-104
CrossRef146
R. Zahn, U. Zeymer. (2008) Interventionelle Therapie des akuten Herzinfarkts. Der Internist 49:9, 1038-1046
CrossRef147
Christian Juhl Terkelsen, Torsten Toftegaard Nielsen. (2008) Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology 52:11, 966-967
CrossRef148
Alois Suessenbacher, Jakob Doerler, Hannes Alber, Josef Aichinger, Johann Altenberger, Werner Benzer, Guenter Christ, Sebastian Globits, Kurt Huber, Ronald Karnik, Georg Norman, Peter Siostrzonek, Gerald Zenker, Otmar Pachinger, Franz Weidinger. (2008) Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry. EuroIntervention 4:2, 271-276
CrossRef149
Harvey D White, Derek P Chew. (2008) Acute myocardial infarction. The Lancet 372:9638, 570-584
CrossRef150
A. Manari, P. Ortolani, P. Guastaroba, G. Casella, L. Vignali, E. Varani, G. Piovaccari, V. Guiducci, G. Percoco, S. Tondi, F. Passerini, A. Santarelli, A. Marzocchi. (2008) Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network. European Heart Journal 29:15, 1834-1842
CrossRef151
Turgay Celik, U. Cagdas Yuksel, Atila Iyisoy, Selim Kilic, Ejder Kardesoglu, Baris Bugan, Ersoy Isik. (2008) The Impact of Preinfarction Angina on Electrocardiographic Ischemia Grades in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention. Annals of Noninvasive Electrocardiology 13:3, 278-286
CrossRef152
Anjan Chakrabarti, Harlan M. Krumholz, Yongfei Wang, John S. Rumsfeld, Brahmajee K. Nallamothu. (2008) Time-to-Reperfusion in Patients Undergoing Interhospital Transfer for Primary Percutaneous Coronary Intervention in the U.S. Journal of the American College of Cardiology 51:25, 2442-2443
CrossRef153
K. Vargová, E. Toth-Zsamboki, B.J. Beres, J. Bencze, G. Kerecsen, P. Gulacsi-Bardos, R.G. Kiss, I. Preda. (2008) Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention. Atherosclerosis 198:2, 366-372
CrossRef154
D. J. Hausenloy, D. M. Yellon. (2008) Preconditioning and postconditioning: new strategies for cardioprotection. Diabetes, Obesity and Metabolism 10:6, 451-459
CrossRef155
Roberto Zanini, Marco Aroldi, Silvia Bonatti, Francesca Buffoli, Antonio Izzo, Corrado Lettieri, Michele Romano, Luca Tomasi, Maria Rosa Ferrari. (2008) Impact of prehospital diagnosis in the management of ST elevation myocardial infarction in the era of primary percutaneous coronary intervention: reduction of treatment delay and mortality. Journal of Cardiovascular Medicine 9:6, 570-575
CrossRef156
Ellis, Stephen G., Tendera, Michal, de Belder, Mark A., van Boven, Ad J., Widimsky, Petr, Janssens, Luc, Andersen, H.R., Betriu, Amadeo, Savonitto, Stefano, Adamus, Jerzy, Peruga, Jan Z., Kosmider, Maciej, Katz, Olivier, Neunteufl, Thomas, Jorgova, Julia, Dorobantu, Maria, Grinfeld, Liliana, Armstrong, Paul, Brodie, Bruce R., Herrmann, Howard C., Montalescot, Gilles, Neumann, Franz-Josef, Effron, Mark B., Barnathan, Elliot S., Topol, Eric J., . (2008) Facilitated PCI in Patients with ST-Elevation Myocardial Infarction. New England Journal of Medicine 358:21, 2205-2217
Full Text157
Robert C Welsh, Paul W Armstrong. 2008. Treatment Opportunities with Fibrinolytic Therapy. , 71-90.
CrossRef158
Henning Kelbæk, Christian J. Terkelsen, Steffen Helqvist, Jens F. Lassen, Peter Clemmensen, Lene Kløvgaard, Anne Kaltoft, Thomas Engstrøm, Hans E. Bøtker, Kari Saunamäki, Lars R. Krusell, Erik Jørgensen, Hans-Henrik T. Hansen, Evald H. Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Leif Thuesen. (2008) Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology 51:9, 899-905
CrossRef159
Thomas P Wharton. 2008. Primary PCI with Off-Site Cardiac Surgery Backup. , 155-166.
CrossRef160
Brahmajee K. Nallamothu. 2008. Interhospital Transfer for Primary PCI. , 167-175.
CrossRef161
Marc Fisher, Edward Folland. (2008) Acute Ischemic Coronary Artery Disease and Ischemic Stroke: Similarities and Differences. American Journal of Therapeutics 15:2, 137-149
CrossRef162
Giuseppe De Luca, Harry Suryapranata, Paolo Marino. (2008) Reperfusion Strategies in Acute ST-Elevation Myocardial Infarction: An Overview of Current Status. Progress in Cardiovascular Diseases 50:5, 352-382
CrossRef163
Carlo Di Mario, Dariusz Dudek, Federico Piscione, Waldemar Mielecki, Stefano Savonitto, Ernesto Murena, Konstantinos Dimopoulos, Antonio Manari, Achille Gaspardone, Andrzej Ochala, Krzysztof Zmudka, Leonardo Bolognese, Philippe Gabriel Steg, Marcus Flather. (2008) Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. The Lancet 371:9612, 559-568
CrossRef164
Hans O. Peels, Gillian A.J. Jessurun, Iwan C.C. van der Horst, Alfons E.R. Arnold, Lieuwe H. Piers, Felix Zijlstra. (2008) Outcome in transferred and nontransferred patients after primary percutaneous coronary intervention for ischaemic out-of-hospital cardiac arrest. Catheterization and Cardiovascular Interventions 71:2, 147-151
CrossRef165
Eugene B. Wu, Nipun Arora, Andrew C. Eisenhauer, Frederic S. Resnic. (2008) An analysis of door-to-balloon time in a single center to determine causes of delay and possibilities for improvement. Catheterization and Cardiovascular Interventions 71:2, 152-157
CrossRef166
Le May, Michel R., So, Derek Y., Dionne, Richard, Glover, Chris A., Froeschl, Michael P.V., Wells, George A., Davies, Richard F., Sherrard, Heather L., Maloney, Justin, Marquis, Jean-François, O'Brien, Edward R., Trickett, John, Poirier, Pierre, Ryan, Sheila C., Ha, Andrew, Joseph, Phil G., Labinaz, Marino, . (2008) A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction. New England Journal of Medicine 358:3, 231-240
Full Text167
Martin Sillesen, Maria Sejersten, Søren Strange, Søren Loumann Nielsen, Freddy Lippert, Peter Clemmensen. (2008) Referral of patients with ST-segment elevation acute myocardial infarction directly to the catheterization suite based on prehospital teletransmission of 12-lead electrocardiogram. Journal of Electrocardiology 41:1, 49-53
CrossRef168
Warren J. Cantor, David Fitchett, Bjug Borgundvaag, Michael Heffernan, Eric A. Cohen, Laurie J. Morrison, Anatoly Langer, Shamir Mehta, Charles Lazzam, Brian Schwartz, Vladimir Dzavik, Shaun G. Goodman. (2008) Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). American Heart Journal 155:1, 19-25
CrossRef169
Tze-Wen Chung, Shoei-Shen Wang, Wei-Jain Tsai. (2008) Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Biomaterials 29:2, 228-237
CrossRef170
Christopher E. Buller, Robert C. Welsh, Cynthia M. Westerhout, John G. Webb, Blair O'Neill, Richard Gallo, Paul W. Armstrong. (2008) Guideline adjudicated fibrinolytic failure: Incidence, findings, and management in a contemporary clinical trial. American Heart Journal 155:1, 121-127
CrossRef171
Seung-Jea Tahk, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Hyeon-Cheol Gwon, Geu-Ru Hong, Young-Jo Kim, Seung-Ho Hur, Kwon-Bae Kim, Bon-Kwon Koo, Seung-Hwan Lee, Junghan Yoon. (2008) Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: A prospective, randomized, multicenter trial. International Journal of Cardiology 123:2, 162-168
CrossRef172
Pavel P. Osmancik, Petr Stros, Dalibor Herman. (2008) In‐hospital arrhythmias in patients with acute myocardial infarction—the relation to the reperfusion strategy and their prognostic impact. Acute Cardiac Care 10:1, 15-25
CrossRef173
Marco De Carlo, Daniele Maselli, Bernardo Cortese, Nicola Ciabatti, Roberto Gistri, Maurizio Levantino, Alberto Balbarini, Raffaele De Caterina, Anna Sonia Petronio. (2008) Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors. International Journal of Cardiology 123:3, 229-233
CrossRef174
Young Bin Song, Joo-Yong Hahn, Hyeon-Cheol Gwon, Jun Hyung Kim, Sang Hoon Lee, Myung-Ho Jeong, . (2008) The Impact of Initial Treatment Delay Using Primary Angioplasty on Mortality among Patients with Acute Myocardial Infarction: from the Korea Acute Myocardial Infarction Registry. Journal of Korean Medical Science 23:3, 357
CrossRef175
Marco Zimarino, Daniele Sacchetta, Giulia Renda, Raffaele De Caterina. (2008) Facilitated PCI: Rationale, Current Evidence, Open Questions, and Future Directions. Journal of Cardiovascular Pharmacology 51:1, 3-10
CrossRef176
Antonio Manari, Corrado Tomasi, Vincenzo Guiducci, Patrizia Zanoni, Gianluca Pignatelli, Paola Giacometti. (2008) Time to treatment and ST-segment resolution in high-risk patients with acute myocardial infarction transferred from community hospitals for coronary angioplasty after pharmacological treatment. Journal of Cardiovascular Medicine 9:1, 32-38
CrossRef177
J. Brent Myers, Corey M. Slovis, Marc Eckstein, Jeffrey M. Goodloe, S. Marshal Isaacs, James R. Loflin, C. Crawford Mechem, Neal J. Richmond, Paul E. Pepe. (2008) Evidence-Based Performance Measures for Emergency Medical Services Systems: A Model for Expanded EMS Benchmarking. Prehospital Emergency Care 12:2, 141-151
CrossRef178
Nana Valeur, Peter Clemmensen, Peer Grande, Kristian Wachtell, Kari Saunamäki. (2008) Pre-Discharge Exercise Test for Evaluation of Patients with Complete or Incomplete Revascularization following Primary Percutaneous Coronary Intervention: A DANAMI-2 Sub-Study. Cardiology 109:3, 163-171
CrossRef179
Jeppe N. Rasmussen, Søren Rasmussen, Gunnar H. Gislason, Steen Z. Abildstrom, Tina K. Schramm, Christian Torp-Pedersen, Lars Køber, Finn Diderichsen, Merete Osler, Mette Madsen. (2007) Persistent Socio-economic Differences in Revascularization After Acute Myocardial Infarction Despite a Universal Health Care System—A Danish Study. Cardiovascular Drugs and Therapy 21:6, 449-457
CrossRef180
Nazli Janjua, Jonathan L Brisman. (2007) Endovascular treatment of acute ischaemic stroke. The Lancet Neurology 6:12, 1086-1093
CrossRef181
Beate Heissig, Leif R. Lund, Haruyo Akiyama, Makiko Ohki, Yohei Morita, John Rømer, Hiromitsu Nakauchi, Ko Okumura, Hideoki Ogawa, Zena Werb, Keld Danø, Koichi Hattori. (2007) The Plasminogen Fibrinolytic Pathway Is Required for Hematopoietic Regeneration. Cell Stem Cell 1:6, 658-670
CrossRef182
M. Cohen, G. Roubin, F. Kuepper. (2007) The challenge of ST-segment elevation myocardial infarction. International Journal of Clinical Practice 61:12, 2079-2092
CrossRef183
Michael Kindermann, Oliver Adam, Nikos Werner, Michael Böhm. (2007) Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007. Clinical Research in Cardiology 96:11, 767-786
CrossRef184
Adam J. Singer, Amit Shembekar, Farid Visram, Joshua Schiller, Valerie Russo, William Lawson, Carol A. Gomes, Carolyn Santora, Mary Maliszewski, Lisa Wilbert, Eileen Dowdy, Peter Viccellio, Mark C. Henry. (2007) Emergency Department Activation of an Interventional Cardiology Team Reduces Door-to-Balloon Times in ST-Segment-Elevation Myocardial Infarction. Annals of Emergency Medicine 50:5, 538-544
CrossRef185
Hans O. Peels, Hans de Swart, Tjeerd v.d. Ploeg, Raymond W. Hautvast, Jan H. Cornel, Alf E. Arnold, Thomas P. Wharton, Victor A. Umans. (2007) Percutaneous Coronary Intervention With Off-Site Cardiac Surgery Backup for Acute Myocardial Infarction as a Strategy to Reduce Door-to-Balloon Time. The American Journal of Cardiology 100:9, 1353-1358
CrossRef186
Nana Valeur, Peter Clemmensen, Peer Grande, Kari Saunamäki. (2007) Prognostic Evaluation by Clinical Exercise Test Scores in Patients Treated With Primary Percutaneous Coronary Intervention or Fibrinolysis for Acute Myocardial Infarction (a Danish Trial in Acute Myocardial Infarction-2 Sub-Study). The American Journal of Cardiology 100:7, 1074-1080
CrossRef187
Patrick Garceau, Jean-Pierre Déry, Philippe Lachance, Stéfanie Grenier, Josep Rodés-Cabau, Gérald Barbeau, Olivier F. Bertrand, Onil Gleeton, Eric Larose, Can Man Nguyen, Bernard Noël, Guy Proulx, Louis Roy, Robert de Larochellière. (2007) Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung Institute. Canadian Journal of Cardiology 23, 53B-57B
CrossRef188
James C. Blankenship, Thomas A. Haldis, G. Craig Wood, Kimberly A. Skelding, Thomas Scott, Francis J. Menapace. (2007) Rapid Triage and Transport of Patients With ST-Elevation Myocardial Infarction for Percutaneous Coronary Intervention in a Rural Health System. The American Journal of Cardiology 100:6, 944-948
CrossRef189
Lars Idorn, Dan Eik Høfsten, Kristian Wachtell, Henning Mølgaard, Kenneth Egstrup. (2007) Prevalence and Prognostic Implications of ST-Segment Deviations from Ambulatory Holter Monitoring After ST-Segment Elevation Myocardial Infarction Treated With Either Fibrinolysis or Primary Percutaneous Coronary Intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy). The American Journal of Cardiology 100:6, 937-943
CrossRef190
Pilar Carrillo, Ramón López-Palop, Eduardo Pinar, Daniel Saura, Manuel Párraga, Francisco Picó, Mariano Valdés, Vicente Bertomeu. (2007) Tratamiento del infarto agudo de miocardio con angioplastia primaria in situ frente a transferencia interhospitalaria para su realización: resultados clínicos a corto y largo plazo. Revista Española de Cardiología 60:8, 801-810
CrossRef191
Amadeo Betriu Gibert. (2007) Importancia del factor tiempo en la elección de la terapia de reperfusión. Revista Española de Cardiología 60:8, 791-793
CrossRef192
Kanwar P. Singh, Robert A. Harrington. (2007) Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. Medical Clinics of North America 91:4, 639-655
CrossRef193
Guy Amit, Carlos Cafri, Harel Gilutz, Reuben Ilia, Doron Zahger. (2007) Benefit of direct ambulance to coronary care unit admission of acute myocardial infarction patients undergoing primary percutanoues intervention. International Journal of Cardiology 119:3, 355-358
CrossRef194
Saumil R. Shah, Claudia P. Hochberg, Duane S. Pinto, C. Michael Gibson. (2007) Reperfusion strategies for ST-elevation myocardial infarction. Current Cardiology Reports 9:4, 281-288
CrossRef195
L. Iri Kupferwasser, Allen M. Amorn, Nikhil Kapoor, Michael S. Lee, Saibal Kar, Bojan Cercek, Suhail Dohad, James Mirocha, James S. Forrester, Prediman K. Shah, Raj R. Makkar. (2007) Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheterization and Cardiovascular Interventions 70:1, 1-8
CrossRef196
E. V. Gelfand, C. P. Cannon. (2007) Myocardial infarction: contemporary management strategies. Journal of Internal Medicine 262:1, 59-77
CrossRef197
Maria Sejersten, Rasmus S. Ripa, Charles Maynard, Peer Grande, Henning Rud Andersen, Galen S. Wagner, Peter Clemmensen. (2007) Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: A DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy. American Heart Journal 154:1, 61.e1-61.e8
CrossRef198
Troy LaBounty, Kim A. Eagle. (2007) Revascularization in the acute coronary syndromes. Biological Rhythm Research 38:3, 259-268
CrossRef199
Grayson G. Geary. (2007) The Vascular Therapist. Heart, Lung and Circulation 16:3, 193-199
CrossRef200
Nina Richling, Harald Herkner, Michael Holzer, Eva Riedmueller, Fritz Sterz, Wolfgang Schreiber. (2007) Thrombolytic therapy vs primary percutaneous intervention after ventricular fibrillation cardiac arrest due to acute ST-segment elevation myocardial infarction and its effect on outcome. The American Journal of Emergency Medicine 25:5, 545-550
CrossRef201
Brian W. Gross, Kent W. Dauterman, Mark G. Moran, Todd S. Kotler, Stephen J. Schnugg, Paul S. Rostykus, Amy M. Ross, W. Douglas Weaver. (2007) An Approach to Shorten Time to Infarct Artery Patency in Patients With ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 99:10, 1360-1363
CrossRef202
(2007) Door-to-Balloon Time in Acute Myocardial Infarction. New England Journal of Medicine 356:14, 1475-1479
Full Text203
Jessica Hahn, Darleen Lessard, Jorge Yarzebski, Jordan Goldberg, Sean Pruell, Frederick A. Spencer, Joel M. Gore, Robert J. Goldberg. (2007) A community-wide perspective into changing trends in the utilization of diagnostic and interventional procedures in patients hospitalized with acute myocardial infarction. American Heart Journal 153:4, 594-605
CrossRef204
Trond Vartdal, Harald Brunvand, Eirik Pettersen, Hans-Jørgen Smith, Erik Lyseggen, Thomas Helle-Valle, Helge Skulstad, Halfdan Ihlen, Thor Edvardsen. (2007) Early Prediction of Infarct Size by Strain Doppler Echocardiography After Coronary Reperfusion. Journal of the American College of Cardiology 49:16, 1715-1721
CrossRef205
Mohsin Farooq, Amer S Qureshi, Iain B Squire. (2007) Early management of ST elevation myocardial infarction: a review of practice. Expert Opinion on Pharmacotherapy 8:4, 401-413
CrossRef206
Pierre-Frédéric Keller, Gilbert Gosselin, Jean Grégoire, Antoine Guédès, Vitali Verin. (2007) Feasibility of the PCI through 6F diagnostic catheters. Catheterization and Cardiovascular Interventions 69:3, 410-415
CrossRef207
Ole Steen Mortensen, Jakob B. Bjorner, Beth Newman, Brian Oldenburg, Mogens Groenvold, Jan K. Madsen, Henning R. Andersen. (2007) Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree. European Journal of Cardiovascular Prevention & Rehabilitation 14:1, 37-43
CrossRef208
Kirsten M. Nielsen, Mogens L. Larsen, Anders Foldspang, Ole Faergeman. (2007) Living alone and atypical clinical presentation are associated with higher mortality in patients with all components of the acute coronary syndrome. European Journal of Cardiovascular Prevention & Rehabilitation 14:1, 152-154
CrossRef209
Jan K. Madsen, Torsten T. Nielsen, Peer Grande, Ulrik H. Eriksen, Kari Saunamäki, Per Thayssen, Eli Kassis, Klaus Rasmussen, Stig Haunsø, Torben Haghfelt, Per Fritz-Hansen, Erik Hjelms, Peter K. Paulsen, Poul Alstrup, Henrik Arendrup, Uffe Niebuhr-Jørgensen, Lars I. Andersen. (2007) Revascularization Compared to Medical Treatment in Patients with Silent vs. Symptomatic Residual Ischemia after Thrombolyzed Myocardial Infarction – The DANAMI Study. Cardiology 108:4, 243-251
CrossRef210
Daniel P. Davis, Cheryl Graydon, Robert Stein, Siobhan Wilson, Barbara Buesch, Shelley Berthiaume, David M. Lee, Jaime Rivas, Gary M. Vilke, Dennis R. Leahy. (2007) The Positive Predictive Value of Paramedic Versus Emergency Physician Interpretation of the Prehospital 12-Lead Electrocardiogram. Prehospital Emergency Care 11:4, 399-402
CrossRef211
2007. M. , 125-137.
CrossRef212
Ellen Bøhmer, Harald Arnesen, Michael Abdelnoor, Arild Mangschau, Pavel Hoffmann, Sigrun Halvorsen. (2007) The NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction (NORDISTEMI). Scandinavian Cardiovascular Journal 41:1, 32-38
CrossRef213
Sebastian Szabo, Uwe Zeymer, Anselm Gitt, Harm Wienbergen, Roger Marx, Tobias Heer, Hans Martin Hoffmeister, Jochen Senges. (2007) Benefit of onsite reperfusion therapy or transfer to primary PCI in STEMI patients admitted to hospitals without catheterization laboratory. Results of the MITRA PLUS Registry. Acute Cardiac Care 9:2, 87-92
CrossRef214
Nicolaj B Støttrup, Steen B Kristiansen, Bo Løfgren, Bo Falck Hansen, Hans-Henrik Kimose, Hans Erik Bøtker, Torsten Toftegaard Nielsen. (2006) l-GLUTAMATE AND GLUTAMINE IMPROVE HAEMODYNAMIC FUNCTION AND RESTORE MYOCARDIAL GLYCOGEN CONTENT DURING POSTISCHAEMIC REPERFUSION: A RADIOACTIVE TRACER STUDY IN THE RAT ISOLATED HEART. Clinical and Experimental Pharmacology and Physiology 33:11, 1099-1103
CrossRef215
D Charytan, R E Kuntz. (2006) The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney International
CrossRef216
Cristina Giglioli, Massimo Margheri, Serafina Valente, Marco Comeglio, Chiara Lazzeri, Tania Chechi, Corinna Armentano, Salvatore Mario Romano, Massimiliano Falai, Gian Franco Gensini. (2006) Timing, setting and incidence of cardiovascular complications in patients with acute myocardial infarction submitted to primary percutaneous coronary intervention. Canadian Journal of Cardiology 22:12, 1047-1052
CrossRef217
P. TORNVALL, T. NILSSON, B. LAGERQVIST. (2006) Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation. Journal of Internal Medicine 260:4, 363-368
CrossRef218
Joshua M. Kosowsky. (2006) Thrombolysis for ST-Elevation Myocardial Infarction in the Emergency Department. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:3, 141-146
CrossRef219
William B. Borden, David P. Faxon. (2006) Facilitated Percutaneous Coronary Intervention. Journal of the American College of Cardiology 48:6, 1120-1128
CrossRef220
David M. Larson, Timothy D. Henry. (2006) Regional Transfer Programs for Primary Percutaneous Coronary Intervention. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:3, 147-152
CrossRef221
Hendrik-Jan Dieker, Elvira V. Horssen, Ferry M. R. J. Hersbach, Marc A. Brouwer, Ad J. Boven, Arnoud W. J. Hof, Wim R. M. Aengevaeren, Freek W. A. Verheugt, Frits W. H. M. Bär. (2006) Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). Journal of Thrombosis and Thrombolysis 22:1, 39-45
CrossRef222
Myl??ne Kosseim, Nancy E. Mayo, Susan Scott, James A. Hanley, James Brophy, Bruno Gagnon, Louise Pilote. (2006) Ranking Hospitals According to Acute Myocardial Infarction Mortality. Medical Care 44:7, 664-670
CrossRef223
Craig I. Coleman, Raymond G. McKay, William E. Boden, Jeffrey F. Mather, C. Michael White. (2006) Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals. Clinical Therapeutics 28:7, 1054-1062
CrossRef224
Ralph G. Brindis, Edward Fischer, Gary Besinque, Alan Gjedsted, Philip C. Lee, Tom Padgett, Michael Petru, Jenni Raley, Eleanor Levin, Anita Strohmeier. (2006) Acute Coronary Syndromes Clinical Practice Guidelines. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:2, 69-102
CrossRef225
Kirsten Hall Long, Erin K. McMurtry, Ryan J. Lennon, Anne C. Chapman, Mandeep Singh, Charanjit S. Rihal, Douglas L. Wood, David R. Holmes, Henry H. Ting. (2006) Elective Percutaneous Coronary Intervention Without On-Site Cardiac Surgery. Medical Care 44:5, 406-413
CrossRef226
C. Sorensen, A. Brandes, O. Hendricks, J. Thrane, E. Friis-Hasche, T. Haghfelt, P. Bech. (2006) Depression assessed over 1-year survival in patients with myocardial infarction. Acta Psychiatrica Scandinavica 113:4, 290-297
CrossRef227
Saif S. Rathore, Andrew J. Epstein, Brahmajee K. Nallamothu, Harlan M. Krumholz. (2006) Regionalization of ST-Segment Elevation Acute Coronary Syndromes Care. Journal of the American College of Cardiology 47:7, 1346-1349
CrossRef228
Stephen W. Smith. (2006) ST Segment Elevation Differs Depending on the Method of Measurement. Academic Emergency Medicine 13:4, 406-412
CrossRef229
Pietro Di Pasquale, Sergio Cannizzaro, Gaspare Parrinello, Francesco Giambanco, Giuseppe Vitale, Sergio Fasullo, Sebastiano Scalzo, Filippo Ganci, Nicola La Manna, Filippo Sarullo, Gabriella La Rocca, Salvatore Paterna. (2006) Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings. Journal of Thrombosis and Thrombolysis 21:2, 147-157
CrossRef230
Timothy D. Henry, James M. Atkins, Michael S. Cunningham, Gary S. Francis, William J. Groh, Robert A. Hong, Karl B. Kern, David M. Larson, Erik Magnus Ohman, Joseph P. Ornato, Mary Ann Peberdy, Michael J. Rosenberg, W. Douglas Weaver. (2006) ST-Segment Elevation Myocardial Infarction: Recommendations on Triage of Patients to Heart Attack Centers. Journal of the American College of Cardiology 47:7, 1339-1345
CrossRef231
Andreas Van De Loo, Bernward Saurbier, Johannes Kalbhenn, Frank Koberne, Manfred Zehender. (2006) Primary percutaneous coronary intervention in acute myocardial infarction: Direct transportation to catheterization laboratory by emergency teams reduces door-to-balloon time. Clinical Cardiology 29:3, 112-116
CrossRef232
Prospero B. Gogo. (2006) The Evaluation and Management of Cardiogenic Shock. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:1, 1-6
CrossRef233
Thomas P. Wharton. (2006) Increasing the Speed and Delivery of Primary Percutaneous Coronary Intervention in the Community. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:1, 34-43
CrossRef234
Marino Labinaz, Terri Swabey, Randal Watson, Madhu Natarajan, Wendy Fucile, Bruce Lubelsky, Bruce Sawadsky, Eric Cohen, Kevin Glasgow. (2006) Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: Summary of the Cardiac Care Network of Ontario Consensus Report. Canadian Journal of Cardiology 22:3, 243-250
CrossRef235
Serruys, Patrick W., Kutryk, Michael J.B., Ong, Andrew T.L., . (2006) Coronary-Artery Stents. New England Journal of Medicine 354:5, 483-495
Full Text236
Mette Gaustadnes, Torben F. Ørntoft, Jens Ledet Jensen, Niels Torring. (2006) Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPs. Human Mutation 27:2, 187-194
CrossRef237
Francesco Orso, Aldo Pietro Maggioni. (2006) What Is the Optimal Reperfusion Strategy for Elderly Patients With Acute MI?. The American Journal of Geriatric Cardiology 15:1, 14-18
CrossRef238
Monisha Dutta, Elias Hanna, Pranab Das, Steven R. Steinhubl. (2006) Incidence and Prevention of Ischemic Stroke following Myocardial Infarction: Review of Current Literature. Cerebrovascular Diseases 22:5-6, 331-339
CrossRef239
Laurie J. Morrison, Steven Brooks, Bruce Sawadsky, Andrew McDonald, P. Richard Verbeek. (2006) Prehospital 12-lead Electrocardiography Impact on Acute Myocardial Infarction Treatment Times and Mortality: A Systematic Review. Academic Emergency Medicine 13:1, 84-89
CrossRef240
Juhana Karha, Eric J. Topol. (2006) Primary Percutaneous Coronary Intervention vs. Fibrinolytic Therapy for Acute ST-Elevation Myocardial Infarction in the Elderly. The American Journal of Geriatric Cardiology 15:1, 19-21
CrossRef241
Bruce R. Brodie, Charles Hansen, Thomas D. Stuckey, Scott Richter, Debra S. VerSteeg, Navin Gupta, William E. Downey, Mark Pulsipher. (2006) Door-to-Balloon Time With Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Impacts Late Cardiac Mortality in High-Risk Patients and Patients Presenting Early After the Onset of Symptoms. Journal of the American College of Cardiology 47:2, 289-295
CrossRef242
Henrik K. Kjaergard, Per Hostrup Nielsen, Jan Jesper Andreasen, Daniel Steinbrüchel, Lars Ib Andersen, Klaus Rasmussen, Henning Rud Andersen, Torsten Toftegaard Nielsen, Leif Spange Mortensen. (2006) Coronary artery bypass grafting within the first year after treatment of large acute myocardial infarctions with angioplasty or fibrinolysis. Scandinavian Cardiovascular Journal 40:1, 25-28
CrossRef243
Maria Sejersten, Charles Maynard, Peter Clemmensen. (2006) Effects of Abciximab as adjunctive therapy in primary percutaneous coronary intervention patients (results from the DANAMI‐2 trial). Acute Cardiac Care 8:2, 75-82
CrossRef244
M. Maeng, U. M. Mortensen, J. Kristensen, S. B. Kristiansen, H. R. Andersen. (2006) Hypothermia during reperfusion does not reduce myocardial infarct size in pigs. Basic Research in Cardiology 101:1, 61-68
CrossRef245
M. Dellborg. (2006) PCI in ST-elevation infarction – One flew over the cuckoo's nest. Scandinavian Cardiovascular Journal 40:1, 8-10
CrossRef246
R. Nieuwlaat, M. Lenzen, H.J.G.M. Crijns, M.H. Prins, W.J. Scholte op Reimer, A. Battler, D. Hasdai, N. Danchin, A.K. Gitt, M.L. Simoons, E. Boersma. (2006) Which Factors Are Associated with the Application of Reperfusion Therapy in ST-Elevation Acute Coronary Syndromes?. Cardiology 106:3, 137-146
CrossRef247
Sidney C. Smith, Ted E. Feldman, John W. Hirshfeld, Alice K. Jacobs, Morton J. Kern, Spencer B. King, Douglass A. Morrison, William W. O’Neill, Hartzell V. Schaff, Patrick L. Whitlow, David O. Williams, Elliott M. Antman, Sidney C. Smith, Cynthia D. Adams, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon Ann Hunt, Alice K. Jacobs, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2006) ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. Journal of the American College of Cardiology 47:1, e1-e121
CrossRef248
Michelle O’Donoghue, Marc S. Sabatine. (2006) Appropriate invasive and conservative treatment approaches for patients with ST-Elevation MI. Current Treatment Options in Cardiovascular Medicine 8:1, 3-11
CrossRef249
(2005) Part 5: Acute coronary syndromes. Resuscitation 67:2-3, 249-269
CrossRef250
Milan Sekulic, Bischan Hassunizadeh, Steve McGraw, Shukri David. (2005) Feasibility of early emergency room notification to improve door-to-balloon times for patients with acute ST segment elevation myocardial infarction. Catheterization and Cardiovascular Interventions 66:3, 316-319
CrossRef251
S. Boulé, A. Gongora, M. Randriamora, D. Adala, C. Courteaux, K. Taghipour, A. Rifaï, E. Bearez, G. Hannebicque. (2005) Infarctus du myocarde et thrombolyse : actualités. Annales de Cardiologie et d'Angéiologie 54:6, 344-352
CrossRef252
Chris A. Ghaemmaghami, David R. Burt. (2005) Acute Reperfusion Therapy in Acute Myocardial Infarction. Emergency Medicine Clinics of North America 23:4, 1043-1063
CrossRef253
S??ren Rasmussen, Ann-Dorthe O. Zwisler, Steen Z. Abildstrom, Jan K. Madsen, Mette Madsen. (2005) Hospital Variation in Mortality After First Acute Myocardial Infarction in Denmark From 1995 to 2002. Medical Care 43:10, 970-978
CrossRef254
D. Vaqueriza Cubillo, R. Matía Francés, I. Sánchez Pérez, C. Sáenz de la Calzada Campos. (2005) Tratamiento invasivo del infarto. Criterios de seguimiento y de respuesta. Rehabilitación cardíaca. Medicine - Programa de Formación Médica Continuada Acreditado 9:40, 2662-2670
CrossRef255
Audun Langhelle, Jerry Nolan, Johan Herlitz, Maaret Castren, Volker Wenzel, Eldar Soreide, Johan Engdahl, Petter Andreas Steen. (2005) Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: The Utstein style. Resuscitation 66:3, 271-283
CrossRef256
Mori J. Krantz, Scott J. Haugen, Holly Batal, Carlin S. Long. (2005) Off-Site Percutaneous Coronary Intervention Reduces Hospital Length of Stay in Vulnerable Patients With Acute Myocardial Infarction. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 4:3, 127-130
CrossRef257
Mauro Maioli, Michela Gallopin, Mario Leoncini, Francesco Bellandi, Anna Toso, Roberto Piero Dabizzi. (2005) Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours. Catheterization and Cardiovascular Interventions 65:4, 484-491
CrossRef258
George M Tadros, Elias A Iliadis, Robert F Wilson, Timothy D Henry. (2005) The evolving role of rescue therapy for acute myocardial infarction. Future Cardiology 1:4, 473-478
CrossRef259
Derek P. Chew, Phil Aylward, Harvey D. White. (2005) Facilitated percutaneous coronary intervention: Is this strategy ready for implementation?. Current Cardiology Reports 7:4, 235-241
CrossRef260
Christian Juhl Terkelsen, Jens Flensted Lassen, Bjarne Linde Nørgaard, Torsten Toftegaard Nielsen, Henning Rud Andersen. (2005) When analyses are invalidated by erroneous assumptions. International Journal of Technology Assessment in Health Care 21:03,
CrossRef261
Pietro Di Pasquale, Sergio Cannizzaro, Francesco Giambanco, Sebastiano Scalzo, Giuseppe Tricoli, Sergio Fasullo, Salvatore Paterna. (2005) Immediate Versus Delayed Facilitated Percutaneous Coronary Intervention. Journal of Cardiovascular Pharmacology 46:1, 83-88
CrossRef262
Michael Haude, Rainer Schulz, Gerd Heusch, Raimund Erbel. (2005) Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarction. Expert Review of Cardiovascular Therapy 3:4, 667-680
CrossRef263
Christian Juhl Terkelsen. (2005) Response to commentaries by Kildemoes and Kristiansen. International Journal of Technology Assessment in Health Care 21:03,
CrossRef264
(2005) Guías de Práctica Clínica sobre intervencionismo coronario percutáneo. Revista Española de Cardiología 58:6, 679-728
CrossRef265
Giuseppe De Luca, Nicolette Ernst, Harry Suryapranata, Jan Paul Ottervanger, Jan C.A. Hoorntje, A.T. Marcel Gosselink, Jan-Henk Dambrink, Menko-Jan de Boer, Arnoud W.J. van't Hof. (2005) Relation of Interhospital Delay and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Transferred for Primary Coronary Angioplasty. The American Journal of Cardiology 95:11, 1361-1363
CrossRef266
David M. Larson, Scott W. Sharkey, Barbara T. Unger, Timothy D. Henry. (2005) Implementation of Acute Myocardial Infarction Guidelines in Community Hospitals. Academic Emergency Medicine 12:6, 522-527
CrossRef267
Mandeep Singh. (2005) Primary angioplasty should be performed in hospitals without on-site surgery. Catheterization and Cardiovascular Interventions 65:1, 1-7
CrossRef268
Eulogio García. (2005) Intervencionismo en el contexto del infarto de miocardio. Conceptos actuales. Revista Española de Cardiología 58:5, 567-584
CrossRef269
W. Douglas Weaver. (2005) Why we should not do percutaneous coronary intervention at sites without surgical backup. Catheterization and Cardiovascular Interventions 65:1, 8-9
CrossRef270
A. Dibra, A. Kastrati, H. Sch
hlen, A. Sch
CrossRef271
J.-E. Leroy, C. Bensouda, E. Durand, A. Greffet, A. Scemama, P. Carli, N. Danchin, P. Sauval. (2005) Prise en charge par le Samu de l'infarctus du myocarde avec sus-décalage du segment ST en milieu urbain chez le sujet âgé de plus de 80 ans. Annales de Cardiologie et d'Angéiologie 54:2, 49-54
CrossRef272
Jacques Machecourt, Eric Bonnefoy, Gérald Vanzetto, Pascal Motreff, Stéphanie Marlière, Alain Leizorovicz, Benoit Allenet, Jean Michel Lacroute, Jean Cassagnes, Paul Touboul. (2005) Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center. Journal of the American College of Cardiology 45:4, 515-524
CrossRef273
David Massel. (2005) Primary angioplasty in acute myocardial infarction: Hypothetical estimate of superiority over aspirin or untreated controls. The American Journal of Medicine 118:2, 113-122
CrossRef274
David P Faxon. (2005) Early reperfusion strategies after acute ST-segment elevation myocardial infarction: the importance of timing. Nature Clinical Practice Cardiovascular Medicine 2:1, 22-28
CrossRef275
Hatem Hamood, Nabeel Makhoul, Amin Hassan, Arie Shefer, Uri Rosenschein. (2005) Embolic protection: Limitations of current technology and novel concepts. Acute Cardiac Care 7:4, 176-182
CrossRef276
O. S. Mortensen, J. B. Bjorner, B. Oldenburg, B. Newman, M. Groenvold, J. K. Madsen, H. R. Andersen. (2005) Health-related quality of life one month after thrombolysis or primary PCI in patients with ST-elevation infarction. A DANAMI-2 sub-study.. Scandinavian Cardiovascular Journal 39:4, 206-212
CrossRef277
Peter Clemmensen, Birgit Jurlander. (2005) Primary PCI for ST elevation AMI save lives and money – what more do we want?. Scandinavian Cardiovascular Journal 39:5, 264-266
CrossRef278
Michael R. Sayre, Lynn J. White, Lawrence H. Brown, Susan D. McHenry. (2005) The National EMS Research Strategic Plan. Prehospital Emergency Care 9:3, 255-266
CrossRef279
Randi Selmer, Sigrun Halvorsen, Kurt I. Myhre, Torbjørn F. Wisløff, Ivar Sønbø Kristiansen. (2005) Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction. Scandinavian Cardiovascular Journal 39:5, 276-285
CrossRef280
Peter R Sinnaeve, Frans J Van de Werf. (2004) Global patterns of health care for acute coronary syndromes. Current Opinion in Cardiology 19:6, 625-630
CrossRef281
Volker Schächinger, Birgit Assmus, Martina B. Britten, Jörg Honold, Ralf Lehmann, Claudius Teupe, Nasreddin D. Abolmaali, Thomas J. Vogl, Wolf-Karsten Hofmann, Hans Martin, Stefanie Dimmeler, Andreas M. Zeiher. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Journal of the American College of Cardiology 44:8, 1690-1699
CrossRef282
Edward F. Ellerbeck, Arvind Bhimaraj, Denise Perpich. (2004) Organization of Care for Acute Myocardial Infarction in Rural and Urban Hospitals in Kansas. The Journal of Rural Health 20:4, 363-367
CrossRef283
J.A.L. Smith. (2004) Reducing call-to-needle times: the critical role of pre-hospital thrombolysis. QJM 97:10, 655-661
CrossRef284
Neil K. Goyal, James Giglio, Miriam Lorberbaum, Eileen Hurley, Jennifer Stant, Francesca Esposito, Robert Sciacca, Mark Apfelbaum, LeRoy E. Rabbani. (2004) A Rapid-Response Alphanumeric Paging Design Decreases Door-to-Balloon Times in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Acute Myocardial Infarction. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3:3, 150-153
CrossRef285
Richard V. Aghababian. (2004) Emergency Department Evaluation and Treatment of Patients With ST-Segment Elevation Myocardial Infarction. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3:3, 110-113
CrossRef286
J. W. Weisel, J.-P. Collet. (2004) Packaging is important: accelerated thrombolysis with encapsulated plasminogen activators. Journal of Thrombosis and Haemostasis 2:9, 1545-1547
CrossRef287
J. K. Leach, E. Patterson, E. A. O'Rear. (2004) Distributed intraclot thrombolysis: mechanism of accelerated thrombolysis with encapsulated plasminogen activators. Journal of Thrombosis and Haemostasis 2:9, 1548-1555
CrossRef288
J. H. Flaherty. (2004) Zero Tolerance for Physical Restraints: Difficult But Not Impossible. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:9, M919-M920
CrossRef289
Kristin Madison. (2004) Multihospital System Membership and Patient Treatments, Expenditures, and Outcomes. Health Services Research 39:4p1, 749-770
CrossRef290
Thomas J. Ryan. (2004) The thrombolysis in myocardial infarction risk index. Journal of the American College of Cardiology 44:4, 790-792
CrossRef291
Elliott M. Antman, Daniel T. Anbe, Paul Wayne Armstrong, Eric R. Bates, Lee A. Green, Mary Hand, Judith S. Hochman, Harlan M. Krumholz, Frederick G. Kushner, Gervasio A. Lamas, Charles J. Mullany, Joseph P. Ornato, David L. Pearle, Michael A. Sloan, Sidney C. Smith, Elliott M. Antman, Sidney C. Smith, Joseph S. Alpert, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Raymond J. Gibbons, Gabriel Gregoratos, Jonathan L. Halperin, Loren F. Hiratzka, Sharon Ann Hunt, Alice K. Jacobs, Joseph P. Ornato. (2004) ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary. Journal of the American College of Cardiology 44:3, 671-719
CrossRef292
Robert A. Kloner, Shereif H. Rezkalla. (2004) Cardiac protection during acute myocardial infarction: Where do we stand in 2004?. Journal of the American College of Cardiology 44:2, 276-286
CrossRef293
James L. Orford, Peter B. Berger. (2004) Transport and centralization of acute coronary syndrome care. Current Cardiology Reports 6:4, 292-299
CrossRef294
Peter Moyer, James Feldman, Jon Levine, Joni Beshansky, Harry P. Selker, Brien Barnewolt, David F. M. Brown, Joseph P. Cardoza, Shamai A. Grossman, Alice Jacobs, Benjamin J. Kerman, Carey Kimmelstiel, Richard Larson, Douglas Losordo, Mark Pearlmutter, Charles Pozner, Alberto Ramirez, Kenneth Rosenfield, Thomas J. Ryan, Richard D. Zane, Christopher P. Cannon. (2004) Implications of the Mechanical (PCI) vs Thrombolytic Controversy for ST Segment Elevation Myocardial Infarction on the Organization of Emergency Medical Services. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3:2, 53-61
CrossRef295
Thomas P. Wharton, Lorelei L. Grines, Mark A. Turco, James D. Johnston, Jane Souther, David C. Lew, Ajazuddin Z. Shaikh, William Bilnoski, Sushil K. Singhi, A.Ersin Atay, Nancy Sinclair, Dawn E. Shaddinger, Mark Barsamian, Mariann Graham, Judith Boura, Cindy L. Grines. (2004) Primary Angioplasty in Acute Myocardial Infarction at Hospitals With No Surgery On-Site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty. Journal of the American College of Cardiology 43:11, 1943-1950
CrossRef296
I. Scott, J. Chan, C. Aroney, G. Carroll. (2004) Local thrombolysis or rapid transfer for primary angioplasty for patients presenting with ST segment elevation myocardial infarction to hospitals without angioplasty facilities. Internal Medicine Journal 34:6, 373-377
CrossRef297
Anne Gammelgaard, Peter Rossel, Ole Steen Mortensen. (2004) Patients’ perceptions of informed consent in acute myocardial infarction research: a Danish study. Social Science & Medicine 58:11, 2313-2324
CrossRef298
Bruce R Brodie. (2004) Primary percutaneous coronary intervention at hospitals without on-site cardiac surgery. Journal of the American College of Cardiology 43:11, 1951-1953
CrossRef299
Richard E Waters, Kanwar P Singh, Matthew T Roe, Mat Lotfi, Michael H Sketch, Kenneth W Mahaffey, L.Kristin Newby, John H Alexander, Robert A Harrington, Robert M Califf, Christopher B Granger. (2004) Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 43:12, 2153-2159
CrossRef300
Jens Kristensen, Ulrik M. Mortensen, S??ren S. Nielsen, Michael Maeng, Anne Kaltoft, Torsten T. Nielsen, Michael Rehling. (2004) Myocardial perfusion imaging with 99mTc sestamibi early after reperfusion reliably reflects infarct size reduction by ischaemic preconditioning in an experimental porcine model. Nuclear Medicine Communications 25:5, 495-500
CrossRef301
Gregory S. Pavlides, Dennis V. Cokkinos. (2004) Reperfusion therapy for acute myocardial infarction: Drugs or devices? is this the right question?. Clinical Cardiology 27:5, 254-256
CrossRef302
Derek L Connolly, Anirban Choudhury, Russell C Davis, Greg Y.H Lip. (2004) A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. Journal of the American College of Cardiology 43:6, 1134-1135
CrossRef303
P. J. M. M. Toll. (2004) Primaire angioplastiek of trombolyse bij het hartinfarct?. MFM 42:3, 81-81
CrossRef304
William W. O'Neill, Simon R. Dixon. (2004) The year in interventional cardiology. Journal of the American College of Cardiology 43:5, 875-890
CrossRef305
Dan Hunt. (2004) Low molecular weight heparin and atherosclerosis. Current Atherosclerosis Reports 6:2, 140-147
CrossRef306
Ikuyoshi Watanabe, Ken Nagao, Shigemasa Tani, Tomiya Ohba, Ken Arima, Kouji Ohiwa, Naoki Masuda, Takeo Anazawa, Katsuo Kanmatsuse, Toshio Kushiro. (2004) Relationship Between the Generation and the Facilitated Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction. Circulation Journal 68:12, 1117-1122
CrossRef307
Arthur M Pancioli, Thomas G Brott. (2004) Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Acute Ischaemic Stroke. CNS Drugs 18:14, 981-988
CrossRef308
Joseph S. Alpert. (2004) Angioplasty or pharmacologic thrombolysis or both for ST-elevation myocardial infarction: The current debate. Current Cardiology Reports 6:1, 1-2
CrossRef309
Henrik Kjaergard, Per Hostrup Nielsen, Jan Jesper Andreasen, Daniel Steinbrüchel, Lars Ib Andersen, Klaus Rasmussen, Henning Rud Andersen, Torsten Toftegaard Nielsen. (2004) Coronary artery bypass grafting within 30 days after treatment of acute myocardial infarctions with angioplasty or fibrinolysis – a surgical substudy of DANAMI‐2. Scandinavian Cardiovascular Journal 38:3, 143-146
CrossRef310
J.-P. Cambou, N. Danchin, Y. Boutalbi, G. Hanania, R. Humbert, P. Clerson, L. Vaur, P. Guéret, D. Blanchard, N. Genès, J.-M. Lablanche. (2004) Évolution de la prise en charge et du pronostic de l'infarctus du myocarde en France entre 1995 et 2000 : résultats des études USIK 1995 et USIC 2000. Annales de Cardiologie et d'Angéiologie 53:1, 12-17
CrossRef311
Elisabeth Ståhle. (2004) Revascularization after treatment for acute ST‐elevation myocardial infarction – CABG is an option. Scandinavian Cardiovascular Journal 38:3, 135-136
CrossRef312
Myung Ho Jeong. (2004) Percutaneous Coronary Intervention for Coronary Artery Disease. Journal of the Korean Medical Association 47:8, 736
CrossRef313
(2003) Coronary Angioplasty versus Fibrinolytic Therapy in Acute Myocardial Infarction. New England Journal of Medicine 349:22, 2167-2169
Full Text314
Jacobs, Alice K., . (2003) Primary Angioplasty for Acute Myocardial Infarction — Is It Worth the Wait?. New England Journal of Medicine 349:8, 798-800
Full Text315
C SHIRODARIA. (2002) What's new in & Ischaemic heart disease and MI. Medicine 30:5, 1-4
CrossRef
- Letters
